Fusion Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference

PR Newswire

HAMILTON, Ontario and BOSTON, Nov. 12, 2020 /PRNewswire/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that the Company will participate in a “fireside chat” presentation at the Jefferies Virtual London Healthcare Conference on Thursday, November 19, 2020 at 8:30am EST / 1:30pm GMT. Presenting on behalf of Fusion will be Chief Executive Officer John Valliant, Ph.D., Chief Financial Officer John Crowley, and Chief Medical Officer James O’Leary, M.D.

A live webcast of the event will be available on the “Events and Presentations” page in the “Investors and Media” section of the Company’s website at https://ir.fusionpharma.com/events-webcasts. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.  

About Fusion
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Employing a proprietary Fast-Clear linker technology, Fusion connects alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha emitting payloads to tumors. Fusion’s lead program, FPI-1434, is currently in a Phase 1 clinical trial.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/fusion-pharmaceuticals-to-present-at-the-jefferies-virtual-london-healthcare-conference-301172266.html

SOURCE Fusion Pharmaceuticals Inc.

Adams Natural Resources Fund Declares Year-End Distribution; Meets Its Annual 6% Minimum Distribution Rate Commitment

PR Newswire

BALTIMORE, Nov. 12, 2020 /PRNewswire/ — Adams Natural Resources Fund, Inc. (NYSE: PEO) declared today a year-end distribution of $0.43 per share. The total distributions by the Fund for 2020 will be $0.73, including the distributions totaling $0.30 per share made prior to today’s announcement. The annual distribution rate represented by these distributions is 6.1%.

The year-end distribution consists of the following:

  • $0.20 per share from 2020 net investment income; and
  • $0.23 per share from net capital gains realized during 2020, comprised all of long-term gain.

This marks the 69th consecutive year that the Fund has paid out capital gains and the 86th consecutive year it has paid out dividends to its shareholders.

Commenting on the year-end distribution, Mark E. Stoeckle, CEO of Adams Natural Resources Fund, said: “Despite the challenging year in Energy, we are proud to continue our long history of providing a substantial distribution to our shareholders. We are pleased to announce our 2020 distribution rate of 6.1%. This exceeds our commitment to distribute least at 6% of the Fund’s trailing 12-month average month-end market price to shareholders.”

The payable date for the distribution is December 18, 2020, the record date is November 23, 2020, and the ex-dividend date is November 20, 2020. The year-end distribution is payable in stock and/or cash at the option of each shareholder.

Details regarding the annual distribution rates and the Fund’s 6% minimum distribution commitment can be found at adamsfunds.com.

###

Since 1929, Adams Funds has consistently helped generations of investors reach their investment goals. Adams Funds is comprised of two closed-end funds, Adams Diversified Equity Fund, Inc. (NYSE: ADX) and Adams Natural Resources Fund, Inc. (NYSE: PEO). The Funds are actively managed by an experienced team with a disciplined approach and have paid dividends for more than 80 years across many market cycles. The Funds are committed to paying an annual distribution rate of 6% or more, providing reliable income to long-term investors. Shares can be purchased through our transfer agent or through a broker. For more information about Adams Funds, please visit: adamsfunds.com.

Contact:

Lyn Walther

Director of Shareholder Communications
800.638.2479 [email protected]  

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/adams-natural-resources-fund-declares-year-end-distribution-meets-its-annual-6-minimum-distribution-rate-commitment-301172367.html

SOURCE Adams Funds

Adams Diversified Equity Fund Declares Year-End Distribution; Exceeds Its Annual 6% Minimum Distribution Rate Commitment

PR Newswire

BALTIMORE, Nov. 12, 2020 /PRNewswire/ — Adams Diversified Equity Fund, Inc. (NYSE: ADX) declared today a year-end distribution of $0.88 per share. The total distributions by the Fund for 2020 will be $1.03, including the distributions totaling $0.15 per share made prior to today’s announcement. The annual distribution rate represented by these distributions is 6.8%.

The year-end distribution consists of the following:

  • $0.07 per share from 2020 net investment income; and
  • $0.81 per share from net capital gains realized during 2020, comprised all of long-term gain.

This marks the 56th consecutive year that the Fund has paid out capital gains and the 85th consecutive year it has paid out dividends to its shareholders.

Commenting on the year-end distribution, Mark E. Stoeckle, CEO of Adams Diversified Equity Fund, said: “In what has been a challenging year for everyone, we are proud to continue our long history of providing a substantial distribution to our shareholders. We are pleased to announce our 2020 distribution rate of 6.8%, which exceeds our commitment to distribute at least 6% of the Fund’s trailing 12-month average month-end market price.”

The payable date for the distribution is December 23, 2020, the record date is November 23, 2020, and the ex-dividend date is November 20, 2020. The year-end distribution is payable in stock and/or cash at the option of each shareholder.

Details regarding the annual distribution rates and the Fund’s 6% minimum distribution commitment can be found at adamsfunds.com.

###

Since 1929, Adams Funds has consistently helped generations of investors reach their investment goals. Adams Funds is comprised of two closed-end funds, Adams Diversified Equity Fund, Inc. (NYSE: ADX) and Adams Natural Resources Fund, Inc. (NYSE: PEO). The Funds are actively managed by an experienced team with a disciplined approach and have paid dividends for more than 80 years across many market cycles. The Funds are committed to paying an annual distribution rate of 6% or more, providing reliable income to long-term investors. Shares can be purchased through our transfer agent or through a broker. For more information about Adams Funds, please visit: adamsfunds.com.

Contact:

Lyn Walther

Director of Shareholder Communications
800.638.2479  │ [email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/adams-diversified-equity-fund-declares-year-end-distribution-exceeds-its-annual-6-minimum-distribution-rate-commitment-301172257.html

SOURCE Adams Funds

Autodesk Announces Executive Change

CFO Scott Herren Departing Company; Autodesk Expects Q3 Results Above Guidance Range

PR Newswire

SAN RAFAEL, Calif., Nov. 12, 2020 /PRNewswire/ — Autodesk, Inc. (Nasdaq: ADSK) today announced the departure of Scott Herren, the company’s senior vice president and chief financial officer. After more than six years at Autodesk, Herren is leaving the design and engineering software leader in mid-December to become chief financial officer at Cisco.

“Scott has played a critical role in driving the business over the last six years and was instrumental in helping Autodesk successfully navigate the business model transition,” said Andrew Anagnost, Autodesk president and CEO. “I want to thank Scott for the many contributions he has made to Autodesk and wish him continued success in the next chapter of his career.”

“It’s been a great run and I am proud to have been part of six transformational years at Autodesk,” said Herren. “It has been a pleasure working with everybody at the company, growing an exceptionally talented finance organization and establishing a leadership position in design and make technology. With the transition to a SaaS business model now complete, I leave knowing Autodesk is well positioned for the future.”

Autodesk has initiated a selection process for a new chief financial officer. Fiscal third quarter 2021 results, which will be reported on November 24th, 2020, are expected to be above Autodesk’s guidance range across all Q3 guidance metrics. The company remains confident in its fiscal 2023 financial goals and the long-term potential from digitization across AEC, the convergence of design and make in manufacturing, and the monetization of non-compliant and legacy users.


Safe Harbor Statement

This press release contains forward-looking statements that involve risks and uncertainties, including quotations from management and statements about our financial goals, our strategies, industry and product potential, performance, and results. There are a significant number of factors that could cause actual results to differ materially from statements made in this press release, including: failure to achieve our revenue and profitability objectives; failure to successfully manage transitions to new business models and markets; failure to maintain cost reductions or otherwise control our expenses; difficulty in predicting revenue from new businesses and the potential impact on our financial results from changes in our business models; developments in the COVID-19 pandemic and the resulting impact on our business and operations; general market, political, economic, and business conditions, including from an economic downturn or recession in the United States or in other countries around the world; any imposition of new tariffs or trade barriers; the impact of non-cash charges on our financial results; fluctuation in foreign currency exchange rates; the success of our foreign currency hedging program; our performance in particular geographies, including emerging economies; the ability of governments around the world to meet their financial and debt obligations, and finance infrastructure projects; weak or negative growth in the industries we serve; slowing momentum in subscription billings or revenues; difficulties encountered in integrating new or acquired businesses and technologies; the inability to identify and realize the anticipated benefits of acquisitions; the financial and business condition of our reseller and distribution channels; dependence on and the timing of large transactions; pricing pressure; unexpected fluctuations in our annual effective tax rate; significant effects of tax legislation and judicial or administrative interpretation of tax regulations, including the Tax Cuts and Jobs Act; the timing and degree of expected investments in growth and efficiency opportunities; changes in the timing of product releases and retirements; and any unanticipated accounting charges. Our estimates as to tax rate are based on current tax law, including current interpretations of the Tax Cuts and Jobs Act, and could be affected by changing interpretations of that Act, as well as additional legislation and guidance around that Act.

Further information on potential factors that could affect the financial results of Autodesk are included in Autodesk’s Form 10-K and subsequent forms 10-Q, which are on file with the U.S. Securities and Exchange Commission. Autodesk disclaims any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.


About Autodesk
 
Autodesk makes software for people who make things. If you’ve ever driven a high-performance car, admired a towering skyscraper, used a smartphone, or watched a great film, chances are you’ve experienced what millions of Autodesk customers are doing with our software. Autodesk gives you the power to make anything. For more information visit autodesk.com or follow @autodesk. 

Autodesk is a registered trademark of Autodesk, Inc., and/or its subsidiaries and/or affiliates in the USA and/or other countries. All other brand names, product names or trademarks belong to their respective holders. Autodesk reserves the right to alter product and services offerings, and specifications and pricing at any time without notice and is not responsible for typographical or graphical errors that may appear in this document. 

© 2020 Autodesk, Inc. All rights reserved. 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/autodesk-announces-executive-change-301172325.html

SOURCE Autodesk, Inc.

Fidelity National Financial, Inc. Announces Virtual Participation at Stephens Annual Investment Conference

PR Newswire

JACKSONVILLE, Fla., Nov. 12, 2020 /PRNewswire/ — Fidelity National Financial, Inc. (NYSE: FNF) (the “Company”) today announced that the Company’s President, Mike Nolan, Chief Financial Officer, Tony Park, and FGL Holdings’ President and Chief Executive Officer, Chris Blunt, will participate in a fireside chat at the Stephens Annual Investment Conference at 4:00 p.m. Eastern Time on Wednesday, November 18, 2020. 

A live webcast and replay of the presentation will be available through FNF’s Investor Relations website at www.fnf.com.  Management will also be available for one-on-one and small group meetings with investors.


About Fidelity National Financial, Inc.

Fidelity National Financial, Inc. (NYSE: FNF) is a leading provider of title insurance and transaction services to the real estate and mortgage industries. FNF is the nation’s largest title insurance company through its title insurance underwriters – Fidelity National Title, Chicago Title, Commonwealth Land Title, Alamo Title and National Title of New York – that collectively issue more title insurance policies than any other title company in the United States. More information about FNF can be found at fnf.com.


About F&G

F&G is part of the FNF family of companies. F&G is committed to helping Americans turn their aspirations into reality. F&G is a leading provider of annuity and life insurance products and is headquartered in Des Moines, Iowa. For more information, please visit www.fglife.com.

FNF-G

Cision View original content:http://www.prnewswire.com/news-releases/fidelity-national-financial-inc-announces-virtual-participation-at-stephens-annual-investment-conference-301172318.html

SOURCE Fidelity National Financial, Inc.

Cisco Appoints R. Scott Herren As Executive Vice President And Chief Financial Officer

PR Newswire

SAN JOSE, Calif., Nov. 12, 2020 /PRNewswire/ —


News Summary:

  • Herren’s appointment is the latest in a focused talent strategy to maximize long-term shareholder value and build recurring revenue for Cisco.
  • Herren brings strong experience in software and a proven track record of leading a successful business model transition from perpetual licenses to SaaS and recurring subscriptions.
  • Herren succeeds Kelly Kramer who will retire after nine years with Cisco.

Cisco (NASDAQ: CSCO) announced today that R. Scott Herren will join the company as executive vice president and chief financial officer on December 18, 2020. Herren will succeed Kelly Kramer who will retire after serving nine years with Cisco. Herren will report directly to Cisco Chairman and Chief Executive Officer Chuck Robbins.

“I want to thank Kelly for her tremendous contributions to Cisco and for the role she has played in shaping our business towards more software and subscription offers and setting the foundation for our future success. She has been an incredible partner, leader and friend and we wish her the best in her retirement,” said Robbins. 

“I am excited for Scott to join the Cisco executive leadership team. With a background in software, Scott will be instrumental in helping us accelerate our shift towards a software-based business model. Scott’s experience operating in complex global environments and proven track record of profitable business growth, prudent financial controls and building winning teams will be a tremendous addition to Cisco,” Robbins added.

“I’m honored to join the team at Cisco during such an important time in the company’s evolution,” said Herren. “The opportunity to contribute to the business-model transformation work already underway is exciting, and the possibilities of what Cisco can achieve are truly inspiring. I look forward to partnering with not only the leadership team, but the entire company, on their journey of transformation.”

Since November 2014, Herren served as chief financial officer and senior vice president of Autodesk where he helped the company successfully transform its business model from perpetual licenses to SaaS and recurring subscriptions. Prior to joining Autodesk, Herren was senior vice president of finance at Citrix Systems where he led the company’s finance, accounting, tax, treasury, investor relations, real estate and facilities teams and held a variety of leadership roles during his 14-year tenure. Before Citrix, Herren spent more than 15 years in senior strategy and financial positions at FedEx and IBM.

Herren holds a Bachelor of Industrial Engineering from Georgia Institute of Technology and a Master of Business Administration degree in Finance from Columbia University.

About Cisco
Cisco (NASDAQ: CSCO) is the worldwide leader in technology that powers the Internet. Cisco inspires new possibilities by reimagining your applications, securing your data, transforming your infrastructure, and empowering your teams for a global and inclusive future. Discover more on The Network and follow us on Twitter at @Cisco.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. To view a list of Cisco trademarks, go to: www.cisco.com/go/trademarks. Third-party trademarks mentioned in this document are the property of their respective owners. The use of the word partner does not imply a partnership relationship between Cisco and any other company.  


Press Contact:           


Investor Relations Contact:

Robyn Jenkins-Blum      

Marilyn Mora    

+1 408 930 8548

+1 408 527 7452


[email protected]         


[email protected]

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cisco-appoints-r-scott-herren-as-executive-vice-president-and-chief-financial-officer-301172299.html

SOURCE Cisco

VolitionRx Limited Announces Third Quarter 2020 Financial Results and Business Update

Conference call to discuss financial and operational results scheduled for Friday, November 13 at 8:30 a.m. U.S. Eastern Time

PR Newswire

  • Launch of first product, the Nu.Q™ Vet Cancer Screening Test planned for November 30, 2020
  • Engaged Diagnostic Oncology CRO LLC to conduct U.S. clinical trial for Non-Hodgkin’s Lymphoma
  • Expanded research program for the use of Nu.Q™ technology in NETosis

AUSTIN, Texas, Nov. 12, 2020 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced financial results and a business update for the third quarter ended September 30, 2020. Volition management will host a conference call tomorrow, November 13 at 8:30 a.m. U.S. Eastern Time to discuss these results. Conference call details may be found below.

Cameron Reynolds, President and Chief Executive Officer of Volition commented: “During the third quarter, despite the persistence of the COVID-19 pandemic, we have made significant progress on many fronts and are on track to launch our first product, the Nu.Q™ Vet Cancer Screening Test, on November 30. This is a pivotal moment for Volition, demonstrating that our platform has the reliability and reproducibility to launch in an independent laboratory.”

 

Mr. Reynolds added, “We have also made considerable progress in our human cancer program and, in particular, in blood cancer where we have obtained similar results in both humans and dogs using the same assay. Based on these promising results, we have engaged Diagnostic Oncology CRO LLC as a contract research organization to conduct a U.S. clinical trial for Non-Hodgkin’s Lymphoma. I am proud of the way our team has adapted to the different world we find ourselves in and has kept working at full speed. It is their efforts and tenacity that have made possible these milestones and the many others that we have achieved this quarter and year to date.”

Company Highlights


Financial

  • Cash and cash equivalents as of September 30, 2020 totalled approximately $21 million compared with $17 million as of December 31, 2019.
  • We continue to manage our expenditures carefully, and as we approach launch and commercialization our burn rate is approximately $1.6$1.7 million per month.


Nu.Q™ Vet Cancer Screening Test Commercial Launch

  • Launch date of Nu.Q™ Vet Cancer Screening Test planned for November 30, 2020.
  • This test will initially be positioned for use in the annual health check of older dogs (those that are seven years and older) and for cases where there is a high suspicion of cancer.
  • The test will be available from the GI Lab at Texas A&M University to potentially thousands of veterinarians across Texas and the rest of the U.S.
  • Significant potential market opportunity into the millions of tests per year as there are approximately 77 million dogs in the U.S.
  • Revenue to Volition is expected to be $45 per test and generate a greater than 85% gross margin.
  • Pre-launch marketing efforts are underway, including a report entitled “A Look to the Future of Cancer Diagnostics” which compiles contributions from some of the key opinion leaders in the veterinary oncology space. A downloadable copy is available here.


Nu.Q™ Vet Cancer Screening Test: Clinical Data

  • The Nu.Q™ Vet Cancer Screening Test is a simple, low-cost, easy to use ELISA based screening blood test which will help streamline the screening process for up to 1/3 of cancers in dogs including common malignancies such as lymphoma and hemangiosarcoma.
  • Two abstracts were presented at the Veterinary Cancer Society Virtual Annual Conference in October 2020.
  • In a study of over 330 dogs conducted by Texas A&M University, the Nu.QTM Vet Cancer Screening Test gave good clinical discrimination with an AUC of 87.3% for lymphoma and 97.6% for hemangiosarcoma.
  • At 100% Specificity the Nu.Q™ Vet Cancer Screening Test demonstrated detection rates of 74% of lymphoma and 89% of hemangiosarcoma.


Clinical – New US Regulatory Study

  • Engaged Diagnostic Oncology CRO LLC, the largest U.S. Contract Research Organization specializing in oncology purposed in-vitro diagnostic device clinical trials, to conduct a U.S. clinical trial for Non-Hodgkin’s Lymphoma (NHL).
  • The trial is designed to obtain multiple FDA-approved adjunct tests to aid in the diagnosis of the five most common and aggressive forms of NHL.
  • The trial will enroll up to 1,500 subjects across 10 major U.S. healthcare institutions over 22 months.
  • This extensive program will cost approximately $2.9 million over two years assuming the completion of numerous projects and includes not only the clinical study but also data analysis and regulatory and reimbursement submission preparation.
  • Existing data suggests Nu.Q™ technology will greatly aid physicians in distinguishing NHL from common conditions, fulfilling what we feel is a critical unmet clinical need which represents a major market opportunity.
  • We expect our first FDA 510K submission will be possible approximately 10-12 months into the trial.


Clinical – NETosis including COVID-19

  • We have made great progress on the research program for the use of our Nu.Q™ technology in NETosis and in particular in monitoring disease progression of COVID-19.
  • Several studies have either been collected or are being negotiated in Europe and we anticipate the next results will be reported before the end of this year.
  • We are also negotiating a large FDA trial for use of our assays in neutrophil extracellular traps (NETs) for COVID-19 and influenza in the U.S. and will announce the full details once they have been finalized.
  • We have filed a novel patent for this application and plan to utilise results of these trials and other ongoing studies to further our aim of developing a clinically useful product to help in the battle against the COVID-19 pandemic and potentially other diseases such as influenza and sepsis.


Expansion

  • We are in the final paperwork stages for “Silver One” the production hub for our products and components close to our Lab in Belgium.
  • Facility will be the production hub of all of our products and components, to both secure our own supply at a lower cost, and to drive reagent revenue, building on our purchase of Octamer GmbH (now called Volition Germany) earlier this year.
  • We plan to achieve full ISO certification next year.
  • Our plan is to produce, at large scale, raw materials such as recombinant nucleosomes, which act as the calibrant to our Nu.Q™ assays, in addition to antibodies that are key elements to our branded products. We plan to manufacture our full diagnostic kits once finalized.
  • We expect to offer all elements, including a service lab provision, for both commercial sale and for clinical trial purposes and CE-marked products for Europe and beyond.
  • To drive revenue, we have appointed our first Sales Manager who starts in December.
  • We have also opened a small, shared laboratory at California State University in San Marcos, California where we will focus on blue-sky innovation and discovery research.


Assay Development and Clinical Studies (Cancer)

  • In various ways our “Marquee trials” have now been affected by the continued pandemic either by slower or paused collection, or a host of other supply chain or travel and communication issues. We believe we have successfully managed those areas under our direct control (such as assay development and running samples – both on track with our milestones) but many issues are not within our control.
  • We have now successfully completed 12 Nu.Q™ discovery grade assays on subsets of both of our National Taiwan University studies – colorectal and lung cancers – and are working on data analysis.
  • An abstract has been accepted regarding Nu.Q™ performance in lung cancer detection for presentation at the upcoming IASLC conference in January 2021. We expect to submit the colorectal cancer data to upcoming conferences.


Upcoming Milestones

Volition expects to achieve the following milestones during 2020 and beyond:

  • Launch of the Nu.Q™ Vet Cancer Screening Test in the U.S.
  • Complete the purchase and fit out of “Silver One”, to serve as our manufacturing hub and service lab in Belgium.
  • Focus on driving revenue in the coming quarters, where possible during the pandemic, in four key areas:

– Nu.Q™ Vet products
– Disease monitoring tests (e.g. COVID-19)
– Reagent sales
– Licensing of our technology for others to commercialize.

  • Continue to advance our previously announced large-scale colorectal and lung cancer trials in Europe, Asia and the U.S.
  • Publish several abstracts and peer-reviewed scientific papers with clinical results as well as showing the robustness and utility of our Nu.Q™ platform.
  • Advance the development of Nu.Q™ Capture.
  • Announce patient data demonstrating the wide utility of our epigenetic toolbox.
  • Continue to file patents to expand and extend our Intellectual Patent portfolio.

VolitionRx Limited Third Quarter 2020 Earnings and Business Update Conference Call

Date:
Friday, November 13, 2020

Time:
8:30 a.m. U.S. Eastern time
U.S. & Canada Dial-in: 1-877-407-9716 (toll free)
U.K. Dial-in: 0 800 756 3429 (toll free)
Toll/International: 1-201-493-6779
Conference ID:   13713126

Cameron Reynolds, President and Chief Executive Officer of Volition, will host the call along with David Vanston, Chief Financial Officer and Scott Powell, Executive Vice President, Investor Relations.

A live audio webcast of the conference call will also be available on the investor relations page of Volition’s corporate website at http://ir.volition.com.

In addition, a telephone replay of the call will be available until November 27, 2020. The replay dial-in numbers are 1-844-512-2921 (toll-free) in the U.S. and Canada and 1-412-317-6671 (toll) internationally. Please use replay pin number 13713126.

About Volition

Volition is a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients, but also to improve their quality of life. The tests are based on the science of NucleosomicsTM, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid – an indication that disease is present. Volition is primarily focused on human diagnostics but also has a subsidiary focused on animal diagnostics.

Volition’s research and development activities are centered in Belgium, with a small laboratory in California and additional offices in Texas, London and Singapore, as the company focuses on bringing its diagnostic products to market.

For more information about Volition, visit Volition’s website volition.com or connect with us via:

Twitter: https://twitter.com/volitionrx 
LinkedIn: https://www.linkedin.com/company/volitionrx 
Facebook: https://www.facebook.com/VolitionRx/
YouTube: https://www.youtube.com/user/VolitionRx

The contents found at Volition’s website address, Twitter, LinkedIn, Facebook, and YouTube are not incorporated by reference into this document and should not be considered part of this document.  The addresses for Volition’s website, Twitter, LinkedIn, Facebook, and YouTube are included in this document as inactive textual references only.

Media / Investor Contacts


Louise Batchelor, Volition


[email protected] 


+44 (0)7557 774620


Scott Powell, Volition


[email protected]


+1 (646) 650 1351


Jen Lewis, Pegasus


[email protected]


+44 (0)7809 867943


Joseph Green, Edison Advisors


[email protected]


+1 (646) 653 7030

Safe Harbor Statement

Statements in this press release may be “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that concern matters that involve risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in the forward-looking statements. Words such as “expects,” “anticipates,” “intends,” “plans,” “aims,” “targets,” “believes,” “seeks,” “estimates,” “optimizing,” “potential,” “goal,” “suggests,” “could,” “would,” “should,” “may,” “will” and similar expressions identify forward-looking statements. These forward-looking statements relate to the timing, completion and delivery of data from clinical studies, the effectiveness of Volition’s blood-based diagnostic and prognostic tests, Volition’s ability to develop and successfully commercialize such test platforms for early detection of cancer and other diseases as well as serving as a diagnostic or prognostic tool for COVID-19, the timing of product launches and publications, and the timing and completion of the acquisition of the additional facility in Belgium. Volition’s actual results may differ materially from those indicated in these forward-looking statements due to numerous risks and uncertainties, including, without limitation, results of studies testing the efficacy of its tests. For instance, if Volition fails to develop and commercialize diagnostic or prognostic products, it may be unable to execute its plan of operations. Other risks and uncertainties include Volition’s failure to obtain necessary regulatory clearances or approvals to distribute and market future products; a failure by the marketplace to accept the products in Volition’s development pipeline or any other diagnostic or prognostic products Volition might develop; Volition’s failure to secure adequate intellectual property protection; Volition will face fierce competition and Volition’s intended products may become obsolete due to the highly competitive nature of the diagnostics market and its rapid technological change; downturns in domestic and foreign economies; and other risks identified in Volition’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as well as other documents that Volition files with the Securities and Exchange Commission. These statements are based on current expectations, estimates and projections about Volition’s business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Forward-looking statements are made as of the date of this release, and, except as required by law, Volition does not undertake an obligation to update its forward-looking statements to reflect future events or circumstances.

Nucleosomics™ and Nu.Q™ and their respective logos are trademarks and/or service marks of VolitionRx Limited and its subsidiaries. All other trademarks, service marks and trade names referred to in this press release are the property of their respective owners. Additionally, unless otherwise specified, all references to “$” refer to the legal currency of the United States of America.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/volitionrx-limited-announces-third-quarter-2020-financial-results-and-business-update-301172376.html

SOURCE VolitionRx Ltd

The Westaim Corporation Reports 2020 Third Quarter Results

 The Westaim Corporation Reports 2020 Third Quarter Results

 Note: All dollar amounts in this press release are expressed in U.S. dollars, except as otherwise noted.

The financial results are reported under International Financial Reporting Standards, except as otherwise noted.

TORONTO–(BUSINESS WIRE)–
The Westaim Corporation (“Westaim” or the “Company”) (TSXV: WED) today announced its financial results for the third quarter ended September 30, 2020. Westaim recorded a net profit of $0.6 million (nil earnings per diluted share) and a net loss of $20.0 million ($0.14 loss per diluted share) for the three and nine months ended September 30, 2020, respectively, compared to a net profit of $3.7 million ($0.03 earnings per diluted share) and a net profit of $21.6 million ($0.15 earnings per diluted share) in the three and nine months ended September 30, 2019, respectively. Book value per share was $2.33 (C$3.10) at September 30, 2020, compared to $2.48 (C$3.22) at December 31, 2019.

Key Results for the three months ended September 30, 2020 (with comparisons to the same period in 2019) include:

  • HIIG: The fair value of HIIG increased $3.3 million in the quarter compared to $2.7 million. The underwriting result has improved from the prior period resulting in a total combined ratio of 96.3% compared to 99.3%. Underwriting actions taken by new management contributed to the gross written premium decreasing 17.8% in the quarter as HIIG re-underwrote some existing businesses, and exited underperforming businesses including monoline workers’ compensation and lawyers and insurance agent professional liability, while accelerating growth in other segments of the business. HIIG’s growth strategy is focused on the remaining businesses and new opportunities where HIIG, with its intermediaries, have specialty expertise and/or key relationships with the target customer base.
  • Arena FINCOs: The fair value of Arena FINCOs increased $0.4 million (+0.2% net return) in the quarter compared to $1.3 million (+0.9% net return). On September 29, 2020, Arena Finance II, LLC (“AFII”), one of the Arena FINCOs, secured a private placement of $45 million of 6.75% senior secured notes to improve net returns by leveraging invested assets. The net proceeds received from these notes will be used by the Arena FINCOs in accordance with their investment objectives.
  • Arena Investors: Westaim’s share of Arena Investors’ net loss in the quarter was $0.3 million compared to a net loss of $0.5 million. Arena Investors had an increase in revenue from higher incentive fees than the prior year by $1.3 million (Westaim’s share of the increase of $0.6 million). This increase in revenues was partially offset by higher expenses as the platform built was being completed.

“Our Q3 results underscore the “third inning” directional objectives shared with stakeholders in Westaim’s September 22nd, 2020 Investor Day. Within HIIG, Andrew Robinson’s laser focus on execution and achieving first quartile performance is starting to be reflected in our underwriting results.” said J. Cameron MacDonald, President and Chief Executive Officer of Westaim. “Industry conditions remain quite favourable for profitable growth with US composite insurance pricing up in excess of 10%, and as highlighted during the Investor Day, any business lines that do not achieve an acceptable return on invested capital will be corrected or culled. Importantly, Andrew continues to attract high quality professionals and pursue opportunities that collectively will contribute to our growth and results. We are excited about the trajectory of HIIG as we move into 2021.”

“Arena Investors achieved several key milestones in the third quarter. Firstly, we completed a $45 million non-recourse note issue at AFII, one of the Arena FINCOs, which is expected to accelerate our ability to enhance returns on our proprietary capital on a prudent basis. Secondly, Arena Investors continues to excel in delivering solid performance throughout a volatile period allowing the firm to be a recipient of four industry performance awards in 2020, including the Bloomberg Hedgeweek Multi-strategy Fund of the Year announced on October 26th. It is worth noting that since Arena’s 2015 inception, over 200 credits have been executed by the Arena team delivering cumulative gross returns to date of approximately $345 million. With four offices and a team of 61 around the globe, Arena is well positioned to provide investors diversified, non-correlated consistent returns. Lastly, as of November 1st, committed and invested assets under management has grown to $1.7B. We expect the positive inflow of AUM to continue, and look forward to delivering operating leverage in the business moving forward.”

Key Results for the nine months ending September 30, 2020 (with comparisons to the same period in 2019) include:

  • HIIG: Along with the purchase of $44.0 million of HIIG convertible preferred shares, the Company recorded a fair value decrease in HIIG of $14.7 million in the first nine months of 2020. This decrease included a reduction in the first quarter of $14.9 million from the change in the HIIG valuation multiple from 1.1X to 1.0X adjusted book value. HIIG’s underwriting results produced a combined ratio excluding LPT of 97.5% compared to 99.0%.
  • Arena FINCOs: The fair value of the Arena FINCOs decreased $1.6 million (-0.9% net return) over the first nine months of 2020 compared to an increase of $9.1 million (+5.6% net return). The net returns have been positive in the last two quarters after reporting a -2.0% net return in the first quarter of 2020.
  • Arena Investors: Westaim’s share of Arena Investors’ net loss for the first nine months of 2020 was $1.5 million compared to a net profit of $0.2 million. Arena Investors had a decrease in revenue from lower incentive fees than the prior year by $3.6 million (Westaim’s share of the decrease of $1.8 million).

This press release should be read in conjunction with the Company’s unaudited interim financial statements, accompanying notes and Management Discussion and Analysis (“MD&A”) for the three and nine months ended September 30, 2020 and with our annual Consolidated Financial Statements and MD&A for the year ended December 31, 2019, which can be found on SEDAR at www.sedar.com and on the Company’s website www.westaim.com.

Non-GAAP Financial Measures

Westaim uses both International Financial Reporting Standards (“IFRS”) and non-generally accepted accounting principles (“non-GAAP”) measures to assess performance. The Company cautions readers about non-GAAP measures that do not have a standardized meaning under IFRS and are unlikely to be comparable to similar measures used by other companies. Book value per share is a non-GAAP measure. Readers are urged to review Section 15 Non-GAAP Measures in Westaim’s Management’s Discussion and Analysis in respect of its unaudited consolidated financial statements for the three and nine months ended September 30, 2020 and 2019 (the “MD&A”) for additional disclosure regarding these measures. The financial information relating to the Arena Group and HIIG contained in the MD&A is unaudited and has been derived from the financial statements of the related entities. Readers are cautioned that the HIIG financial information and certain Arena Group financial information, including any non-GAAP measures contained therein, has not been reconciled to IFRS and so may not be comparable to the financial information of issuers that present their financial information in accordance with IFRS.

About Westaim

Westaim is a Canadian investment company specializing in providing long-term capital to businesses operating primarily within the global financial services industry. The Company invests, directly and indirectly, through acquisitions, joint ventures and other arrangements, with the objective of providing its shareholders with capital appreciation and real wealth preservation. Westaim’s strategy is to pursue investment opportunities with a focus towards the financial services industry and grow shareholder value over the long term. Westaim’s investments include significant interests in HIIG and the Arena Group. HIIG, the HIIG Partnership, Arena, the Arena Group, Arena FINCOs, Arena Finance II, LLC, and Arena Investors are defined in the notes to Westaim’s unaudited consolidated financial statements for the three and nine months ended September 30, 2020 and 2019 and the MD&A. Westaim’s Common Shares are listed on the TSX Venture Exchange under the trading symbol WED.

For more information, contact:

J. Cameron MacDonald, President and Chief Executive Officer or

Robert T. Kittel, Chief Operating Officer

The Westaim Corporation

[email protected]

(416)969-3333

The Westaim Corporation

Financial Highlights

(millions of U.S. dollars except share and per share data)

Highlights

 

Three months ended September 30

 

Nine months ended September 30

(millions except share and per share data)

 

2020

 

2019

 

2020

 

2019

 

 

 

 

 

 

 

 

 

Revenue and net change in unrealized value of investments

 

$

4.0

 

 

$

4.8

 

 

$

(16.1

)

 

$

29.3

 

Net expenses

 

 

(3.4

)

 

 

(1.1

)

 

 

(3.8

)

 

 

(7.7

)

Income tax expense

 

 

 

 

 

 

 

(0.1

)

 

 

 

Profit (loss) and comprehensive income (loss)

 

$

0.6

 

 

$

3.7

 

 

$

(20.0

)

 

$

21.6

 

 

 

 

 

 

 

 

 

 

Earnings (loss) per share – basic

 

$

 

 

$

0.03

 

 

$

(0.14

)

 

$

0.15

 

Earnings (loss) per share – diluted

 

$

 

 

$

0.03

 

 

$

(0.14

)

 

$

0.15

 

 

 

 

 

 

 

 

 

 

 

 

September 30, 2020

 

December 31, 2019

Assets

 

 

 

 

Cash

 

$

8.3

 

$

22.2

Income tax receivable

 

 

0.5

 

 

0.4

Other assets

 

 

1.5

 

 

2.3

Investments

 

 

377.3

 

 

385.8

 

 

$

387.6

 

$

410.7

 

 

 

 

 

Liabilities

 

 

 

 

Accounts payable and accrued liabilities

 

$

9.4

 

$

10.7

Income tax payable

 

 

0.3

 

 

0.4

Preferred securities

 

 

37.6

 

 

38.5

Derivative warrant liability

 

 

0.8

 

 

1.9

Site restoration provision

 

 

4.1

 

 

4.1

Deferred tax liability

 

 

0.4

 

 

0.3

 

 

 

52.6

 

 

55.9

 

 

 

 

 

Shareholders’ equity

 

 

335.0

 

 

354.8

Total liabilities and shareholders’ equity

 

$

387.6

 

$

410.7

 

 

 

 

 

 

 

 

 

 

Number of common shares outstanding1

 

 

143,186,718

 

 

143,186,718

Book value per share – in US$2

 

$

2.33

 

$

2.48

Book value per share – in C$2

 

$

3.10

 

$

3.22

 

 

 

 

 

 1  

At September 30, 2020 and December 31, 2019, an aggregate of 3,034,261 RSUs, 10,428,337 stock options and 14,285,715 warrants were also outstanding. Details regarding these RSUs, stock options and warrants are disclosed in the Company’s public filings including its quarterly and annual financial statements which are available under the Company’s profile on SEDAR at www.sedar.com.

 2  

Non-GAAP measure. See Section 15, Non-GAAP Measures of the MD&A for a reconciliation to the most comparable IFRS figures.

   

Period end exchange rates: 1.33125 at September 30, 2020 and 1.29865 at December 31, 2019.

Except for statements of historical fact contained herein, information in this press release may constitute “forward-looking information” within the meaning of Canadian securities laws. Other than statements of historical fact, all statements that involve various known and unknown risks, uncertainties and other factors are “forward-looking statements”. There can be no assurance that such statements will prove accurate. Results and future events could differ materially from those anticipated in such statements. Readers of this press release are cautioned not to place undue reliance on these “forward-looking statements”. Except as otherwise required by applicable law, Westaim expressly disclaims any intention or obligation to update publicly any forward-looking information, whether as a result of new information, future events or otherwise. The information provided herein does not constitute an offer or solicitation regarding any investment products offered by Arena Group.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The Westaim Corporation

[email protected]

(416)969-3333

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Professional Services Finance

MEDIA:

Logo
Logo

voxeljet AG Reports Financial Results for the Third Quarter Ended September 30, 2020

voxeljet AG Reports Financial Results for the Third Quarter Ended September 30, 2020

FRIEDBERG, Germany–(BUSINESS WIRE)–
voxeljet AG (NASDAQ: VJET) (the “Company”, or “voxeljet”), a leading provider of high-speed, large-format 3D printers and on-demand parts services to industrial and commercial customers, today announced consolidated financial results for the third quarter ended September 30, 2020.

Highlights – Third Quarter 2020 compared to the Third Quarter 2019

  • Total revenues for the third quarter increased 10.6% to kEUR 4,908 from kEUR 4,436
  • Gross profit margin increased to 32.7% from 19.5%
  • Systems revenues increased 64.2% to kEUR 2,686 from kEUR 1,636
  • Services revenues decreased 20.6% to kEUR 2,222 from kEUR 2,800
  • Lowered full year revenue guidance to between kEUR 20,700 and kEUR 22,700
  • Revenue for the fourth quarter of 2020 is expected to be in the range of kEUR 8,000 to kEUR 10,000.

Dr. Ingo Ederer, Chief Executive Officer of voxeljet, commented, “We have reached three significant milestones with VJET X and the new, large High Speed Sintering (“HSS”) 3D printer over the last months: first, we received the follow-up orders for three additional VJET X units. The order comes as part of a frame contract concluded in 2018 between us and our partners and a premium German car maker. Second, just recently, we received the pre-acceptance from the car maker and our partners for the first two units, which were installed in 2019. We expect to recognize revenue for the first batch of five VJET X units mid-2021. Third, in HSS, we have found a clever and self-adjusting solution to address the challenge of having a stable temperature across a large powder bed: we have filed an IP accordingly. First printing tests on the large HSS printer were successful and we are extremely excited about the new opportunities and markets we plan to address with it.”

Three Months Ended September 30, 2020 Results

Revenues for the third quarter of 2020 increased by 10.6% to kEUR 4,908 compared to kEUR 4,436 in the third quarter of 2019.

Revenues from our Systems segment, which focuses on the development, production and sale of 3D printers, increased 64.2% to kEUR 2,686 in the third quarter of 2020 from kEUR 1,636 in last year’s third quarter. The Company sold two used and refurbished 3D printers in the third quarter of 2020 compared to three new 3D printers in last year’s third quarter. Revenue from the sale of 3D printers significantly increased due to the product mix, as we sold larger scale platforms in the third quarter of 2020 as opposed to smaller platforms in the comparative period. Systems revenues also include all Systems-related revenues from consumables, spare parts and maintenance. Those Systems-related revenues increased in the third quarter year over year, which reflects the higher installed base of 3D printers in the market and the associated growth in aftersales activities, although we were not able to achieve the targeted numbers. Revenues from the sale of 3D printers as well as Systems-related revenues were still impacted by the economic slow-down due to the ongoing global pandemic of COVID-19 disease (“the COVID-19 situation”). We were not able to perform all of the installations of 3D printers, which were scheduled for the third quarter of 2020 due to reimpositions of travel restrictions and shutdowns with the resurgence of COVID-19 cases in countries where our clients are located. As a consequence, we were not able to recognize revenue on those transactions. The same issues limited our ability to perform service and maintenance visits world wide, which also adversely affected our opportunities to recognize revenue. As many of our clients have reduced their production activities, the demand for consumables as well as spare and wear parts was on a lower level than expected, nevertheless we saw a recovery of demand compared to the prior two quarters in 2020. Systems revenues represented 54.7% of total revenues in the third quarter of 2020 compared to 36.9% in last year’s third quarter.

Revenues from our Services segment, which focuses on the printing of on-demand parts for our customers, decreased 20.6% to kEUR 2,222 in the third quarter of 2020 from kEUR 2,800 in the comparative period of 2019. This was mainly due to lower revenue contributions from our subsidiary voxeljet America Inc. (“voxeljet America”) related to the COVID-19 situation leading to a significant decrease in demand from our clients in North America. In addition, revenues from our subsidiary voxeljet UK Ltd. (“voxeljet UK”) significantly decreased. This was related to the close down of our service center in the United Kingdom in the fourth quarter of 2019 in the course of our restructuring, which started in the third quarter of 2019. For the German operation as well as for our subsidiary voxeljet China Co. Ltd. (“voxeljet China”), we saw a considerable market recovery in the third quarter of 2020 compared to the second quarter of 2020. Demand from our clients and associated revenues were approximately on the same level as last year’s third quarter.

Cost of sales were kEUR 3,301 for the third quarter of 2020 compared to kEUR 3,571 for the third quarter of 2019.

Gross profit and gross profit margin were kEUR 1,607 and 32.7%, respectively, in the third quarter of 2020 compared to kEUR 865 and 19.5% in the third quarter of 2019.

Gross profit for our Systems segment increased to kEUR 1,060 in the third quarter of 2020 from kEUR 357 in third quarter of 2019. Gross profit margin for this segment increased to 39.5% in the third quarter of 2020 compared to 21.8% in the third quarter of 2019. This was mainly due to higher gross profit and gross profit margin from the sale of 3D printers due to a more favorable product mix. But also gross profit and gross profit margin from Systems-related revenues slightly increased due to the product mix.

Gross profit for our Services segment slightly increased to kEUR 547 in the third quarter of 2020 compared to kEUR 508 in the third quarter of 2019. Gross profit margin for this segment significantly increased to 24.6% in the third quarter of 2020 from 18.1% in the third quarter of 2019. This was mainly due to neutral gross profit as well as gross profit margin contribution from voxeljet UK, as a result of the close down of our service center in the United Kingdom that began in the last year’s third quarter, accompanied by negative contributions. Further, gross profit and gross profit margin contribution from the German operation improved due to cost savings measures implemented as a consequence of the COVID-19 situation. Regarding voxeljet America, the decrease in revenues quarter over quarter led to a lower utilization of the American service center, resulting in significantly lower gross profit and gross profit margin contribution. Gross profit as well as gross profit margin contribution from voxeljet China slightly improved quarter over quarter.

Selling expenses were kEUR 1,295 for the third quarter of 2020 compared to kEUR 1,687 in the third quarter of 2019. Despite an increase in revenues, we recorded a decrease in selling expenses which was mainly due to lower selling expenses from voxeljet UK as a result of the successful restructuring, which started in the last year’s third quarter. In addition, we incurred lower expenses for travelling, trade fairs and exhibitions related to the COVID-19 situation and the associated global restrictions. Usually distributions expenses like shipping and packaging costs are a main driver of the selling expenses and can vary from quarter to quarter depending on quantity and types of products sold, as well as the destinations of where those goods are being delivered.

Administrative expenses were kEUR 1,477 for the third quarter of 2020 compared to kEUR 1,567 in the third quarter of 2019. The decrease was mainly due to significantly lower administrative expense from voxeljet UK as a result of the completed restructuring. This was partially offset by higher consulting fees related to the voluntary transfer of the listing of our American Depositary Shares (“ADSs”) from The New York Stock Exchange (the “NYSE”) to the NASDAQ Capital Market (“NASDAQ”) in August 2020, as previously disclosed in the Company’s filings with the U.S. Securities and Exchange Commission (“SEC”).

Research and development (“R&D”) expenses decreased to kEUR 1,482 in the third quarter of 2020 from kEUR 1,888 in the third quarter of 2019. The decrease of kEUR 406 was mainly due to lower personnel expenses as well as lower material consumption. Those expenses can vary from quarter to quarter and are usually driven by the different project types and phases.

Other operating expenses in the third quarter of 2020 were kEUR 590 compared to kEUR 36 in the prior year period. This was mainly due to higher losses from foreign currency transactions of kEUR 570 for the third quarter of 2020 compared to kEUR 22 for the third quarter of 2019.

Other operating income was kEUR 223 for the third quarter of 2020 compared to kEUR 787 in the third quarter of 2019. The decrease was mainly due to lower gains from foreign currency transactions, which decreased to kEUR 109 for the third quarter of 2020, compared to kEUR 642 in the last year’s third quarter.

The changes in foreign currency losses and gains were primarily driven by the valuation of the intercompany loans granted by the parent company to our UK and US subsidiaries.

Operating loss was kEUR 3,014 in the third quarter of 2020, compared to an operating loss of kEUR 3,526 in the comparative period in 2019. This was mainly related to the significant improvement in gross profit in the third quarter of 2020 compared to the third quarter of 2019. In addition, operating expenses within all functions decreased quarter over quarter, especially within the sales and marketing and R&D functions. This was partially offset by a negative net impact from other operating expenses and other operating income amounting to kEUR 367 for the third quarter of 2020 compared to a positive net impact amounting to kEUR 751 for the third quarter of 2019.

Financial result was negative kEUR 928 in the third quarter of 2020, compared to a financial result of negative kEUR 141 in the comparative period in 2019. This was mainly related to higher finance expenses related to the revaluation of derivative financial instruments, amounting to kEUR 481, compared to a finance income of kEUR 74 in the third quarter of 2019. The derivative financial instruments are revalued on each balance sheet date, with changes in the fair value between reporting periods recorded within financial result of the consolidated statements of comprehensive loss. An increase in our share price results in a finance expense, while a decrease leads to a finance income. Interest expense included interest from long term debt with other financial institutions which amounted to kEUR 486 for the third quarter of 2020, compared to kEUR 254 in the comparative period in 2019. The increase is mainly related to the draw down of the second tranche of the loan granted by the European Investment Bank (“EIB”) under the Finance Contract in June 2020 amounting to kEUR 5,000. This second tranche includes both, a Performance Participation Interest (PPI), accounted for separately as derivative financial instruments (included within the revaluation mentioned above) and also a fixed interest, which is recorded as interest from long term debt.

Net loss for the third quarter of 2020 was kEUR 4,035 or EUR 0.82 per share, as compared to net loss of kEUR 3,735, or EUR 0.76 per share, in the third quarter of 2019.

Effective August 14, 2020, we changed the ratio of our American Depositary Shares (“ADSs”) to ordinary shares from each ADS representing one-fifth (1/5) of one ordinary share (5:1) to each ADS representing one ordinary share (1:1). Based on a conversion rate of one ADSs per ordinary share, net loss was at EUR 0.82 per ADS for the third quarter of 2020, compared to a net loss of EUR 0.15 per ADS for the third quarter of 2019, based on a conversion rate of five ADSs per ordinary share. Earnings per share is computed by dividing net income attributable to stockholders of the parent by the weighted-average number of ordinary shares outstanding during the periods. Earnings per ADS is calculated by dividing the above earnings per share by one (before August 14, 2020: five) as each ordinary share represents one (before August 14, 2020: five) ADS(s).

Nine Months Ended September 30, 2020 Results

Revenues for the nine months ended September 30, 2020 decreased by 15.6% to kEUR 12,708 compared to kEUR 15,051 in the prior year period.

Systems revenues were kEUR 5,862 for the first nine months of 2020 compared to kEUR 6,180 for the same period last year. The Company sold two new and three used and refurbished 3D printers during the first nine months of 2020, compared to seven new and one used and refurbished 3D printer in the prior year period. Although, the Company sold a smaller number of units, revenue from the sale of 3D printers slightly increased due to the product mix, as we sold larger scale platforms in the first nine months of 2020 as opposed to smaller platforms in the comparative period in 2019. Nevertheless, the COVID-19 situation, including resurgence of COVID-19 cases and the reimpositions of travel restrictions or even shutdowns in countries where our clients are located, prohibited us from performing all of the scheduled installations of 3D printers. Therefore, we were not able to recognize revenue on those transactions. Systems revenues also include revenues from consumables, spare parts and maintenance. Also, those Systems-related revenues were significantly impacted by the COVID-19 situation, as the performance of service visits was limited in many regions of the world, which made it impossible to fulfill our maintenance schedule. Further, we experienced lower demand for consumables and spare parts in the first nine months of 2020, as our clients have reduced their production activities, especially in the second quarter of 2020. All those matters led to a decrease in Systems-related revenues. In the third quarter of 2020, demand for consumables and spare parts substantially recovered compared to the prior two quarters in 2020. Systems revenues represented 46.1% of total revenue for the nine months ended September 30, 2020 compared to 41.1% for the same period in the prior year.

Services revenues were kEUR 6,846 for the nine months ended September 30, 2020 compared to kEUR 8,871 for the same period last year. This decrease of 22.8% was mainly due to significantly lower revenue contributions from our subsidiary voxeljet America Inc. (“voxeljet America”), related to the COVID-19 situation, leading to a significant decrease in demand from our clients. We incurred similar impacts for the German service center, where revenues also decreased, although not as strong as in the US. Revenue contribution from our subsidiary voxeljet UK Ltd. (“voxeljet UK”) significantly decreased. This was related to the close down of our service center in the United Kingdom in the fourth quarter of 2019 in the course of our restructuring, which started in the third quarter of 2019. Also, revenues from our subsidiary voxeljet China Co. Ltd. (“voxeljet China”) were impacted by the economic slow-down due to COVID-19 and therefore slightly decreased.

Cost of sales for the nine months ended September 30, 2020 were kEUR 8,931, a decrease of kEUR 1,816, over cost of sales of kEUR 10,747 for the same period in 2019.

Gross profit and gross profit margin for the nine months ended September 30, 2020 were kEUR 3,777 and 29.7%, respectively, compared to kEUR 4,304 and 28.6% in the prior year period.

Gross profit for our Systems segment increased to kEUR 2,040 for the nine months ended September 30, 2020 from kEUR 1,717 in the same period in 2019. Also, gross profit margin for this segment improved to 34.8% compared to 27.8% for the prior year period. This was related to a more favorable product mix, especially regarding Systems-related revenues, but also regarding revenues from the sale of 3D printers, as larger scale platforms usually provide higher gross profit (margins) compared to smaller platforms.

Gross profit for our Services segment decreased to kEUR 1,737 for the nine months ended September 30, 2020 from kEUR 2,587 in the same period of 2019. The gross profit margin for this segment decreased to 25.4% for the first nine months of 2020 from 29.2% in the same period in 2019. This was mainly related to significantly lower gross profit as well as gross profit margin contribution from our American service center, as a result of lower utilization in line with the decrease in revenues. Gross profit as well as gross profit margin contribution from our German service center slightly improved year over year in spite of the decline in revenues, due to cost savings measures implemented as a consequence of the COVID-19 situation. Gross profit and gross profit margin contribution from voxeljet China remained almost unchanged.

Selling expenses were kEUR 4,136 for the nine months ended September 30, 2020 compared to kEUR 5,125 in the same period in 2019. The year over year decrease is mainly due to lower distribution expenses corresponding to the decrease in revenues. Shipping and packaging expenses as a main driver of the selling expenses could vary from quarter to quarter depending on quantity and types of products, as well as the destinations where those goods are being delivered. Further, selling expenses from voxeljet UK significantly decreased as a result of the successful restructuring, which started in the last year’s third quarter. In addition, we incurred lower expenses for travelling, trade fairs and exhibitions related to the COVID-19 situation and the associated global restrictions.

Administrative expenses slightly increased by kEUR 103 to kEUR 4,694 for the first nine months of 2020 from kEUR 4,591 in the prior year’s period. The increase was mainly due to higher unexpected advisor fees in the second quarter of 2020, mainly related to the Audit Committee Investigation as previously disclosed in the Company’s SEC filings. This was largely offset by significantly lower administrative expense from voxeljet UK as a result of the completed restructuring.

R&D expenses decreased to kEUR 4,737 for the nine months ended September 30, 2020 from kEUR 5,295 in the same period in 2019, a decrease of kEUR 558. The decrease was mainly due to lower personnel expenses as well as lower material consumption. Those expenses can vary from quarter to quarter and are usually driven by the different project types and phases.

Other operating expenses for the nine months ended September 30, 2020 were kEUR 1,958 compared to kEUR 422 in the prior year period. This was mainly due to higher losses from foreign currency transactions amounting to kEUR 1,859 for the nine months ended September 30, 2020 compared to kEUR 395 in the prior year’s period.

Other operating income was kEUR 1,258 for the nine months ended September 30, 2020 compared to kEUR 1,468 in the prior year period. The decrease was mainly due to lower gains from foreign exchange transactions amounting to kEUR 489 for the nine months ended September 30, 2020 compared to kEUR 1,088 for the comparative period in 2019. This was partially offset by a government grant received by voxeljet America in April 2020 from the United States Small Business Administration (“SBA”) under the COVID-19 funding program amounting to kEUR 295. The full amount was recognized in profit and loss, in the second quarter of 2020, as the related costs for which the grant is intended to compensate, occurred in this period and we assume that we comply with the conditions of the funding. The assessment of SBA whether we are in compliance with the conditions, has not been performed yet.

The changes in foreign currency losses and gains were primarily driven by the valuation of the intercompany loans granted by the parent company to our UK and US subsidiaries.

Operating loss was kEUR 10,490 in the nine months ended September 30, 2020 compared to an operating loss of kEUR 9,661 in the comparative period in 2019. This was primarily driven by the net impact from other operating expenses and other operating income amounted to kEUR 700 negative for the nine months ended September 30, 2020, compared to kEUR 1,046 positive for the nine months ended September 30, 2019. In addition, gross profit decreased significantly, while administrative expenses slightly increased compared to the nine months ended September 30, 2019. This was partially offset by lower operating expenses within the functions sales and marketing and R&D for the nine months ended September 30, 2020 compared to the last year’s same period.

Financial result was negative kEUR 1,119 for the nine months ended September 30, 2020, compared to a financial result of negative kEUR 487 in the comparative period in 2019. This was mainly due to higher interest expense for long-term debt which amounted to kEUR 1,094 in the nine months ended September 30, 2020, compared to kEUR 745 for the nine months ended September 30, 2019. This increase is mainly due to the fixed interest related to the second tranche of the loan granted by the European Investment Bank (“EIB”) under the Finance Contract in June 2020 amounting to kEUR 5,000, which has been drawn down in June 2020. Finance income and expense related to the revaluation of derivative financial instruments amounted to kEUR 486 and kEUR 394, respectively for the nine months ended September 2020, compared to a finance income and expense of kEUR 133 and kEUR 0, respectively in the last year’s same period.

Net loss for the nine months ended September 30, 2020 was kEUR 11,759, or EUR 2.41 per share, as compared to net loss of kEUR 10,271, or EUR 2.09 per share in the prior year period.

Effective August 14, 2020, we changed the ratio of our American Depositary Shares (“ADSs”) to ordinary shares from each ADS representing one-fifth (1/5) of one ordinary share (5:1) to each ADS representing one ordinary share (1:1). Based on a conversion rate of one ADSs per ordinary share, net loss was EUR 2.41 per ADS for the nine months ended September 30, 2020, compared to net loss of EUR 0.42 per ADS in the prior year period, based on a conversion rate of five ADSs per ordinary share.

Business Outlook

Our revenue guidance for the fourth quarter of 2020 is expected to be in the range of kEUR 8,000 to kEUR 10,000. We lowered full year revenue guidance to between kEUR 20,700 and kEUR 22,700 from kEUR 26,000 to kEUR 30,000, mainly due to reimpositions of travel restrictions and closings in countries where our clients are located which caused further delays in scheduled 3D printer installations.

For gross profit margin, we expect gross profit margin to be above 40% for the fourth quarter of 2020 rather than for the full year and adjusted EBITDA to be neutral-to-positive also for the fourth quarter of 2020 rather than for the second half of the year ending December 31, 2020. Those changes are a result of lower than expected gross profit for the third quarter of 2020. For full year guidance, we expect:

– Full year revenue is expected to be in the range of kEUR 20,700 to kEUR 22,700

– Gross profit margin for the fourth quarter of 2020 is expected to be above 40%

– Operating expenses for the full year are expected as follows: selling and administrative expenses are expected to be in the range of kEUR 13,000 to kEUR 13,250 and R&D expenses are projected to be between approximately kEUR 5,750 and kEUR 6,250. Depreciation and amortization expense is expected to be between kEUR 3,500 and kEUR 3,750.

– Adjusted EBITDA for the fourth quarter of 2020 is expected to be neutral-to-positive. Adjusted EBITDA is defined as net income (loss), as calculated under IFRS accounting principles before interest (income) expense, provision (benefit) for income taxes, depreciation and amortization, and excluding other operating (income) expense resulting from foreign exchange gains or losses on the intercompany loans granted to the subsidiaries.

– Capital expenditures are projected to be in the range of kEUR 500 to kEUR 1,000, which primarily includes ongoing investments in our global subsidiaries.

Our total backlog of 3D printer orders at September 30, 2020 was kEUR 9,445, which represents eleven 3D printers. This compares to a backlog of kEUR 2,792 representing three 3D printers, at December 31, 2019. As production and delivery of our printers is generally characterized by lead times ranging between three to nine months, the conversion rate of order backlog into revenue is dependent on the equipping process for the respective 3D printer, as well as the timing of customers’ requested deliveries.

At September 30, 2020, we had cash and cash equivalents of kEUR 5,975 and held kEUR 2,922 of investments in bond funds, thereof kEUR 2,000 restricted, which are included in current financial assets on our consolidated statements of financial position.

Webcast and Conference Call Details

The Company will host a conference call and webcast to review the results for the third quarter 2020 on Friday, November 13, 2020 at 8:30 a.m. Eastern Time. Participants from voxeljet will include its Chief Executive Officer, Dr. Ingo Ederer, and its Chief Financial Officer, Rudolf Franz, who will provide a general business update and respond to investor questions.

Interested parties may access the live audio broadcast by dialing 1-877-705-6003 in the United States/Canada, or 1-201-493-6725 for international, Conference Title “voxeljet AG Third Quarter 2020 Financial Results Conference Call”. Investors are requested to access the call at least five minutes before the scheduled start time in order to complete a brief registration. An audio replay will be available approximately two hours after the completion of the call at 1-844-512-2921 or 1-412-317-6671, Replay Conference ID number 13712044. The recording will be available for replay through November 20, 2020.

A live webcast of the call will also be available on the investor relations section of the Company’s website. Please go to the website https://event.on24.com/wcc/r/2628507/D88FE2EA4FC838A12B6DE062756F809A at least fifteen minutes prior to the start of the call to register, download and install any necessary audio software. A replay will also be available as a webcast on the investor relations section of the Company’s website.

Non-IFRS Measure

Management regularly uses both IFRS and non-IFRS results and expectations internally to assess its overall performance of the business, making operating decisions, and forecasting and planning for future periods. Management believes that Adjusted EBITDA is a useful financial measure to the Company’s investors as it helps investors better understand and evaluate the projections our management board provides. The Company’s calculation of Adjusted EBITDA may not be comparable to similarly titled financial measures reported by other peer companies. Adjusted EBITDA should not be considered as a substitute to financial measures prepared in accordance with IFRS.

The Company uses Adjusted EBITDA as a supplemental financial measure of its financial performance. Adjusted EBITDA is defined as net income (loss), as calculated under IFRS accounting principles, interest (income) expense, provision (benefit) for income taxes, depreciation and amortization, and excluding other (income) expense resulting from foreign exchange gains or losses on the intercompany loans granted to the subsidiaries. Management believes Adjusted EBITDA to be an important financial measure because it excludes the effects of fluctuating foreign exchange gains or losses on the intercompany loans granted to its subsidiaries. We are unable to reasonably estimate the potential full-year financial impact of foreign currency translation because of volatility in foreign exchange rates. Therefore, we are unable to provide a reconciliation to our forward-looking guidance for non-GAAP Adjusted EBITDA without unreasonable effort as certain information necessary to calculate such measure on an IFRS basis is unavailable, dependent on future events outside of our control and cannot be predicted without unreasonable efforts by the Company.

Exchange rate

This press release contains translations of certain U.S. dollar amounts into euros at specified rates solely for the convenience of readers. Unless otherwise noted, all translations from U.S. dollars to euros in this press release were made at a rate of USD 1.1723 to EUR 1.00, the noon buying rate of the Federal Reserve Bank of New York for the Euro on September 30, 2020.

About voxeljet

voxeljet is a leading provider of high-speed, large-format 3D printers and on-demand parts services to industrial and commercial customers. The Company’s 3D printers employ a powder binding, additive manufacturing technology to produce parts using various material sets, which consist of particulate materials and proprietary chemical binding agents. The Company provides its 3D printers and on-demand parts services to industrial and commercial customers serving the automotive, aerospace, film and entertainment, art and architecture, engineering and consumer product end markets. For more information, visit http://www.voxeljet.de/en/.

Cautionary Statement on Forward-Looking Statements

This press release contains forward-looking statements concerning our business, operations and financial performance. Any statements that are not of historical facts may be deemed to be forward-looking statements. You can identify these forward-looking statements by words such as ‘‘believes,’’ ‘‘estimates,’’ ‘‘anticipates,’’ ‘‘expects,’’ ‘‘projects,’’ ‘‘plans,’’ ‘‘intends,’’ ‘‘may,’’ ‘‘could,’’ ‘‘might,’’ ‘‘will,’’ ‘‘should,’’ ‘‘aims,’’ or other similar expressions that convey uncertainty of future events or outcomes. Forward-looking statements include statements regarding our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations concerning, among other things, our results of operations, financial condition, business outlook, the industry in which we operate and the trends that may affect the industry or us. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that forward-looking statements are not guarantees of future performance. All of our forward-looking statements are subject to known and unknown risks, uncertainties and other factors that are in some cases beyond our control and that may cause our actual results to differ materially from our expectations, including those risks identified under the caption “Risk Factors” in the Company’s Annual Report on Form 20-F and in other reports the Company files with the U.S. Securities and Exchange Commission, as well as the risk that our revenues may fall short of the guidance we have provided in this press release. Except as required by law, the Company undertakes no obligation to publicly update any forward-looking statements for any reason after the date of this press release whether as a result of new information, future events or otherwise.

voxeljet AG

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (UNAUDITED)

 

 

 

 

 

 

 

 

 

Notes

 

9/30/2020

 

12/31/2019 (1) (2)

 

 

 

 

(€ in thousands)

 

 

 

 

 

 

 

Current assets

 

 

 

29,182

 

 

31,513

 

Cash and cash equivalents

 

7

 

5,975

 

 

4,368

 

Financial assets

 

7

 

2,922

 

 

7,408

 

Trade receivables

 

7

 

4,630

 

 

5,915

 

Inventories

 

4

 

13,999

 

 

12,459

 

Income tax receivables

 

 

 

30

 

 

39

 

Other assets

 

 

 

1,626

 

 

1,324

 

 

 

 

 

 

 

 

Non-current assets

 

 

 

28,952

 

 

31,052

 

Financial assets (2)

 

7

 

2,765

 

 

2,279

 

Intangible assets

 

 

 

1,199

 

 

1,356

 

Property, plant and equipment

 

5

 

24,919

 

 

27,343

 

Investments in joint venture

 

 

 

27

 

 

30

 

Other assets

 

 

 

42

 

 

44

 

 

 

 

 

 

 

 

Total assets

 

 

 

58,134

 

 

62,565

 

 

 

 

 

 

 

 

 

 

 

Notes

 

9/30/2020

 

12/31/2019 (1) (2)

 

 

 

 

 

 

 

Current liabilities

 

 

 

9,093

 

 

18,855

 

Trade payables

 

7

 

2,095

 

 

2,797

 

Contract liabilities

 

 

 

4,782

 

 

2,623

 

Financial liabilities

 

7

 

1,021

 

 

11,290

 

Other liabilities and provisions

 

6

 

1,195

 

 

2,145

 

 

 

 

 

 

 

 

Non-current liabilities

 

 

 

25,878

 

 

10,192

 

Deferred tax liabilities (2)

 

 

 

331

 

 

142

 

Financial liabilities (2)

 

7

 

25,542

 

 

9,866

 

Other liabilities and provisions

 

6

 

5

 

 

184

 

 

 

 

 

 

 

 

Equity

 

 

 

23,163

 

 

33,518

 

Subscribed capital

 

 

 

4,836

 

 

4,836

 

Capital reserves

 

 

 

88,580

 

 

88,077

 

Accumulated deficit (1) (2)

 

 

 

(71,761

)

 

(60,124

)

Accumulated other comprehensive income (1)

 

 

 

1,643

 

 

742

 

Equity attributable to the owners of the company

 

 

 

23,298

 

 

33,531

 

Non controlling interest

 

 

 

(135

)

 

(13

)

Total equity and liabilities

 

 

 

58,134

 

 

62,565

 

See accompanying notes to unaudited condensed consolidated interim financial statements.

(1)Comparative figures for the year ended December 31, 2019 were revised related to the amendment of classification of short-term investments. For further information, see Note 1 of the interim consolidated financial statements.

(2)Comparative figures for the year ended December 31, 2019 were revised related to the recalculation of the performance participation interest related to the Finance Contract with the EIB. For further information, see Note 1 of the interim consolidated financial statements.

voxeljet AG

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended September 30,

 

Nine months ended September 30,

 

 

Notes

 

2020

 

2019 (1) (2)

 

2020

 

2019 (1) (2)

 

 

 

 

(€ in thousands except share and share data)

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

9, 10

 

4,908

 

 

4,436

 

 

12,708

 

 

15,051

 

Cost of sales

 

 

 

(3,301

)

 

(3,571

)

 

(8,931

)

 

(10,747

)

Gross profit

 

9

 

1,607

 

 

865

 

 

3,777

 

 

4,304

 

Selling expenses

 

 

 

(1,295

)

 

(1,687

)

 

(4,136

)

 

(5,125

)

Administrative expenses

 

 

 

(1,477

)

 

(1,567

)

 

(4,694

)

 

(4,591

)

Research and development expenses

 

 

 

(1,482

)

 

(1,888

)

 

(4,737

)

 

(5,295

)

Other operating expenses

 

 

 

(590

)

 

(36

)

 

(1,958

)

 

(422

)

Other operating income

 

 

 

223

 

 

787

 

 

1,258

 

 

1,468

 

Thereof income (expense) from changes in impairment allowance included in other operating income (expense)

 

 

 

41

 

 

(129

)

 

26

 

 

23

 

Operating loss

 

 

 

(3,014

)

 

(3,526

)

 

(10,490

)

 

(9,661

)

Finance expense (1) (2)

 

8

 

(1,005

)

 

(325

)

 

(1,692

)

 

(934

)

Finance income (1) (2)

 

8

 

77

 

 

184

 

 

573

 

 

447

 

Financial result

 

8

 

(928

)

 

(141

)

 

(1,119

)

 

(487

)

Loss before income taxes

 

 

 

(3,942

)

 

(3,667

)

 

(11,609

)

 

(10,148

)

Income tax expense (2)

 

 

 

(93

)

 

(68

)

 

(150

)

 

(123

)

Net loss

 

 

 

(4,035

)

 

(3,735

)

 

(11,759

)

 

(10,271

)

Other comprehensive income (loss) that may be reclassified subsequently to profit or loss (1)

 

 

 

89

 

 

(209

)

 

901

 

 

(193

)

Total comprehensive loss

 

 

 

(3,946

)

 

(3,944

)

 

(10,858

)

 

(10,464

)

 

 

 

 

 

 

 

 

 

 

 

Loss attributable to:

 

 

 

 

 

 

 

 

 

 

Owners of the Company

 

 

 

(3,955

)

 

(3,668

)

 

(11,637

)

 

(10,105

)

Non-controlling interests

 

 

 

(80

)

 

(67

)

 

(122

)

 

(166

)

 

 

 

 

(4,035

)

 

(3,735

)

 

(11,759

)

 

(10,271

)

 

 

 

 

 

 

 

 

 

 

 

Total comprehensive loss attributable to:

 

 

 

 

 

 

 

 

 

 

Owners of the Company

 

 

 

(3,866

)

 

(3,877

)

 

(10,736

)

 

(10,298

)

Non-controlling interests

 

 

 

(80

)

 

(67

)

 

(122

)

 

(166

)

 

 

 

 

(3,946

)

 

(3,944

)

 

(10,858

)

 

(10,464

)

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of ordinary shares outstanding

 

 

 

4,836,000

 

 

4,836,000

 

 

4,836,000

 

 

4,836,000

 

Loss per share – basic/ diluted (EUR)

 

 

 

(0.82

)

 

(0.76

)

 

(2.41

)

 

(2.09

)

See accompanying notes to unaudited condensed consolidated interim financial statements.

(1)Comparative figures for the three and nine months ended September 30, 2019 were revised related to the amendment of classification of short-term investments. For further information, see Note 1 of the interim consolidated financial statements.

(2)Comparative figures for the three and nine months ended September 30, 2019 were revised related to the recalculation of the performance participation interest related to the Finance Contract with the EIB. For further information, see Note 1 of the interim consolidated financial statements.

voxeljet AG

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Attributable to the owners of the company

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

other

 

 

 

 

 

 

 

 

Subscribed

 

Capital

 

Accumulated

 

comprehensive

 

 

 

Non-controlling

 

 

(€ in thousands)

 

capital

 

reserves

 

deficit

 

gain (loss)

 

Total

 

interests

 

Total equity

Balance at December 31, 2018 (1) (2) (3)

 

4,836

 

86,803

 

(46,410

)

 

1,320

 

 

46,549

 

 

35

 

 

46,584

 

Loss for the period (1) (2)

 

 

 

(10,105

)

 

 

 

(10,105

)

 

(166

)

 

(10,271

)

Foreign currency translations

 

 

 

 

 

(193

)

 

(193

)

 

 

 

(193

)

Equity-settled share-based payment

 

 

501

 

 

 

 

 

501

 

 

 

 

501

 

Share-based payment transaction with the non-controlling shareholder of a subsidiary

 

 

604

 

 

 

 

 

604

 

 

216

 

 

820

 

Balance at September 30, 2019 (1) (2)

 

4,836

 

87,908

 

(56,515

)

 

1,127

 

 

37,356

 

 

85

 

 

37,441

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Attributable to the owners of the company

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

other

 

 

 

 

 

 

 

 

Subscribed

 

Capital

 

Accumulated

 

comprehensive

 

 

 

Non-controlling

 

 

(€ in thousands)

 

capital

 

reserves

 

deficit

 

gain (loss)

 

Total

 

interests

 

Total equity

Balance at December 31, 2019 (1) (2)

 

4,836

 

88,077

 

(60,124

)

 

742

 

33,531

 

 

(13

)

 

33,518

 

Loss for the period

 

 

 

(11,637

)

 

 

(11,637

)

 

(122

)

 

(11,759

)

Foreign currency translations

 

 

 

 

 

901

 

901

 

 

 

 

901

 

Equity-settled share-based payment

 

 

503

 

 

 

 

503

 

 

 

 

503

 

Balance at September 30, 2020

 

4,836

 

88,580

 

(71,761

)

 

1,643

 

23,298

 

 

(135

)

 

23,163

 

See accompanying notes to unaudited condensed consolidated interim financial statements.

(1)Comparative figures for the year ended December 31, 2018, the nine months ended September 30, 2019 and year ended December 31, 2019 were revised related to the amendment of classification of short-term investments. For further information, see Note 1 of the interim consolidated financial statements.

(2)Comparative figures for the year ended December 31, 2018, the nine months ended September 30, 2019 and year ended December 31, 2019 were revised related to the recalculation of the performance participation interest related to the Finance Contract with the EIB. For further information, see Note 1 of the interim consolidated financial statements.

(3)The Company has initially applied IFRS 16 as of January 1, 2019, using the modified retrospective approach. Under this approach, comparative information is not restated and the cumulative effect of initially applying IFRS 16 is recognized in retained earnings at the date of initial application. For further information, see Form 20-F filed with the SEC on May 7, 2020, Part III, Item 18. Financial Statements, Note 3 of the consolidated financial statements.

voxeljet AG

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

 

 

 

 

 

 

 

Nine months ended September 30,

 

 

2020

 

2019 (1) (2)

 

 

(€ in thousands)

 

 

 

 

 

Cash Flow from operating activities

 

 

 

 

 

 

 

 

 

Loss for the period (1) (2)

 

(11,759

)

 

(10,271

)

 

 

 

 

 

Depreciation and amortization

 

2,657

 

 

3,200

 

Foreign currency exchange differences on loans to subsidiaries

 

1,217

 

 

(700

)

Changes in financial assets due to fair value valuation

 

73

 

 

(162

)

Share-based compensation expense

 

503

 

 

501

 

Change in impairment of trade receivables

 

(26

)

 

(23

)

Non-cash expense on financial liabilities

 

1,027

 

 

653

 

Change in fair value of derivative equity forward

 

(92

)

 

(132

)

Change in inventory allowance

 

(1

)

 

(21

)

Interest paid

 

199

 

 

254

 

Interest received

 

(86

)

 

(86

)

Loss on disposal of fixed assets

 

22

 

 

309

 

Other

 

209

 

 

107

 

 

 

 

 

 

Change in working capital

 

2

 

 

528

 

Trade and other receivables, inventories and current assets

 

(886

)

 

75

 

Trade payables

 

(642

)

 

(687

)

Other liabilities, contract liabilities and provisions

 

1,059

 

 

1,176

 

Change in restricted cash

 

463

 

 

 

Income tax payable/receivables

 

8

 

 

(36

)

Net cash used in operating activities

 

(6,055

)

 

(5,843

)

 

 

 

 

 

Cash Flow from investing activities

 

 

 

 

 

 

 

 

 

Payments to acquire property, plant and equipment and intangible assets

 

(182

)

 

(1,133

)

Proceeds from disposal of financial assets

 

4,962

 

 

7,973

 

Payments to acquire financial assets

 

(994

)

 

(1,251

)

Interest received

 

86

 

 

86

 

Others

 

 

 

5

 

Net cash from investing activities

 

3,872

 

 

5,680

 

 

 

 

 

 

Cash Flow from financing activities

 

 

 

 

 

 

 

 

 

Repayment of lease liabilities

 

(332

)

 

(158

)

Repayment of long-term debt

 

(664

)

 

(846

)

Proceeds from issuance of long-term debt

 

5,000

 

 

500

 

Interest paid

 

(199

)

 

(254

)

Net cash used in financing activities

 

3,805

 

 

(758

)

 

 

 

 

 

Net increase (decrease) in cash and cash equivalents

 

1,622

 

 

(921

)

 

 

 

 

 

Cash and cash equivalents at beginning of period

 

4,368

 

 

7,402

 

Changes to cash and cash equivalents due to foreign exchanges rates

 

(15

)

 

92

 

Cash and cash equivalents at end of period

 

5,975

 

 

6,573

 

See accompanying notes to unaudited condensed consolidated interim financial statements.

(1)Comparative figures for the nine months ended September 30, 2019 were revised related to the amendment of classification of short-term investments. For further information, see Note 1 of the interim consolidated financial statements.

(2)Comparative figures for the nine months ended September 30, 2019 were revised related to the recalculation of the performance participation interest related to the Finance Contract with the EIB. For further information, see Note 1 of the interim consolidated financial statements.

voxeljet AG

NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

1. Preparation of financial statements

Our condensed consolidated interim financial statements include the accounts of voxeljet AG and its wholly-owned subsidiaries voxeljet America Inc., voxeljet UK Ltd. and voxeljet India Pvt. Ltd., as well as voxeljet China Co. Ltd., which are collectively referred to herein as the ‘Group’ or the ‘Company’, which is listed on the NASDAQ Capital Market (“NASDAQ”).

As previously disclosed, on August 18, 2020, the Company announced that it would voluntarily transfer the listing of its American Depositary Shares (“ADSs”) from the New York Stock Exchange (the “NYSE”) to the NASDAQ, effective August 28, 2020, after market close. voxeljet’s ADSs began trading as a NASDAQ-listed security at market open on August 31, 2020, and have continued to be listed under the ticker symbol “VJET.”

As previously disclosed, on July 31, 2020, the Company announced that it would change the ratio of its American Depositary Shares (“ADSs”) to ordinary shares from each ADS representing one-fifth (1/5) of one ordinary share (5:1) to each ADS representing one ordinary share (1:1). For ADS holders, the ratio change had the same effect as a 1 for 5 reverse ADS split. The ratio change became effective on August 14, 2020 (the “Effective Date”). On the Effective Date, each ADS holder was required to exchange every five (5) ADSs then held for one (1) new ADS (e.g., if a holder of ADSs previously held 50 ADSs, following the ratio change on the Effective Date, such holder helds 10 ADSs). Citibank, N.A., as depositary bank, has arranged for the exchange of the current ADSs for the new ones. There was no change to voxeljet’s underlying ordinary shares.

Our condensed consolidated interim financial statements were prepared in compliance with all applicable measurement and presentation rules contained in International Financial Reporting Standards (‘IFRS’) as set forth by the International Accounting Standards Board (‘IASB’) and Interpretations of the IFRS Interpretations Committee (‘IFRIC’). The designation IFRS also includes all valid International Accounting Standards (‘IAS’); and the designation IFRIC also includes all valid interpretations of the Standing Interpretations Committee (‘SIC’). Specifically, these financial statements were prepared in accordance with the disclosure requirements and the measurement principles for interim financial reporting purposes specified by IAS 34. Our condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto that are included in the Company’s Annual Report on Form 20-F for the year ended December 31, 2019. The results of operations for the three months ended September 30, 2020, are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2020.

The IASB issued a number of new IFRS standards which are required to be adopted in annual periods beginning after January 1, 2020.

 

 

 

Standard

Effective date

Descriptions

Others

01/2020

Amendments References to the Conceptual Framework in IFRS Standards 3

IFRS 3

01/2020

Amendment Definition of a business

IAS 1, IAS 8

01/2020

Amendment, Amendment Definition of material

IFRS 9, IAS 39, IFRS 7

01/2020

Amendments to IFRS 9, IAS 39 and IFRS 7 – Interest rate benchmark reform

IFRS 16

06/2020

COVID-19 related rent concessions amendment to IFRS 16

IFRS 17

01/2021

Insurance Contracts

IAS 1

01/2022

Classifications of Liabilities as Current or Non-Current (Amendment to IAS 1)

The adoption of standards effective 01/2020 did not have a material impact on the interim financial statements as of and for the three and nine months ended September 30, 2020. The Company has not yet conclusively determined what impact the new standards, amendments or interpretations effective 01/2021 or later will have on its financial statements, but does not expect they will have a significant impact.

The interim financial statements as of and for the three and nine months ended September 30, 2020 and 2019 were authorized for issue by the Management Board on November 12, 2020.

Going concern

The financial statements have been prepared on the basis of going concern which contemplates continuity of normal business activities and the realization of assets and settlement of liabilities in the ordinary course of business.

voxeljet has recognized continuous net losses during the nine months ended September 30, 2020, full year 2019, 2018 and 2017 amounting to kEUR 11,759, kEUR 13,978, kEUR 8,747 and kEUR 8,581, respectively. Additionally, voxeljet had negative cash flows from operating activities in the nine months ended September 30, 2020, full year 2019, 2018 and 2017 of kEUR 6,055, kEUR 6,819, kEUR 7,714 and kEUR 6,830, respectively, mainly due to continuous net losses.

Due to the global outbreak of a new strain of coronavirus, we have experienced and expect to continue to experience lower demand in both, our Systems and Services segment. Our clients have postponed and may continue to postpone larger investments and therefore, the demand for 3D printers may also decrease. In addition, the COVID-19 situation could cause further delays in installation of 3D printers at customers’ facilities, which could lead to postponed revenue recognition for those transactions. In the third quarter of 2020, we experienced a slight recovery of demand compared to the prior two quarters in 2020, but we are still not on the level before the global economic crisis as a consequence of COVID-19. Both a decrease in revenues as well as potential delays in the installations increase the risk and likelihood of lower cash inflows. Such risks have been evaluated by management and consequently have been considered in our liquidity forecast, which assumes our business plan is executed appropriately and sales track as expected. We update our liquidity forecast on an ongoing basis.

As we experience difficulty in generating sufficient cash flow to meet our obligations and sustain our operations, the COVID-19 situation raises material uncertainties that may cast substantial doubt about our ability to continue as a going concern. Further, material deviations from our forecasts could lead to a covenant breach in the future, which could result in an acceleration of our obligation to repay all amounts outstanding under those facilities.

Despite the ongoing losses, reduced cash flow and cash facilities, and the other negative financial conditions, management assumes that voxeljet will continue as a going concern, as the Company has been successful in drawing down kEUR 5,000 of the second tranche of the loan granted by the EIB under the Finance Contract in June 2020. This improved our liquidity significantly. Also, the financial covenants under the Finance Contract have been renegotiated to replace the Total Net Financial Debt to EBITDA ratio with a minimum cash/cash equivalents requirement. In addition, the restructuring of the voxeljet UK entity, which included consolidating 3D printing to serve all customers in Europe from the German service center has been finished. This helps to reduce overall costs and will lead to improved gross profit margins by realizing economies of scale in the German service center. Further, management initiated a restructuring program at the German entity during the fourth quarter of 2019. This program included the reduction of headcount mainly in the Systems segment in order to streamline the Company’s operations and optimize efficiency. This restructuring was successfully completed at the end of June 2020 and will provide further cost reductions.

Management is also taking steps to raise further funds which may include debt or equity financing. There can be no assurance that we will be able to raise further funds on terms favorable to us, if at all.

Based on our current liquidity and capital resources in combination with our current liquidity forecasts, as well as the implemented cost reduction program, management believes that the Company has the ability to meet its financial obligations for at least the next 12 months and therefore continues as a going concern. However, the matters described above give rise to material uncertainties that may cast substantial doubt about the Company’s ability to continue as a going concern.

Impairment test

Non-financial assets are tested for impairment if there are indicators that the carrying amounts may not be recoverable. The Company considers the COVID-19 situation as such an indicator. Therefore, voxeljet performed an impairment test for the non‑financial assets for the end of the reporting period. An impairment loss is recognized in the amount by which the asset’s carrying amount exceeds its recoverable amount. The recoverable amount is defined as the higher of an asset’s fair value less cost to sell and its value in use. As individual assets do not generate largely independent cash flows, impairment testing is performed at the cash generating unit level. An individual fixed asset within a CGU cannot be written down below fair value less cost incurred to sell the individual asset. The impairment test, which we performed, did not lead to any write downs.

Amendment and recalculation

a) Amendment of classification of short-term investments

In the first quarter of 2020, we amended our classification of short-term investments included in current financial assets. Before the amendment, those short-term investments have been classified in the category at fair value through OCI (FVOCI).

The new classification shall be the category at fair value through profit and loss (FVTPL). Accordingly, prior periods have been revised, which leads to movements between profit and loss and other comprehensive income as the changes in fair value are now presented within finance income or expense.

b) Recalculation of performance participation interest related to the Finance Contract with the EIB

In the first quarter of 2020, we recalculated the performance participation interest related to the Finance Contract with the EIB, due to a mistake in the calculation logic. Accordingly, prior periods have been revised, which leads to adjustments in non current financial assets, deferred tax liabilities as well as equity.

c) Impacts of amendment and recalculation

Due to the amendments and recalculations, which are described above, the opening balance as of January 1, 2019 of non current financial assets as well as deferred tax liabilities have increased by kEUR 151 and kEUR 43 respectively. The opening balance as of January 1, 2019 of accumulated deficit increased by kEUR 10, whereas the opening balance of accumulated other comprehensive gain increased by kEUR 119. As a result, the loss for the nine months ended September 2019 decreased by kEUR 346.

As of September 30, 2019, non current financial assets as well as deferred tax liabilities have increased by kEUR 370 and kEUR 104, respectively. For the period ending September 30, 2019 the balance of accumulated deficit decreased by kEUR 336, whereas the balance of accumulated other comprehensive gain decreased by kEUR 69.

As a result, the loss for the three months ended September 2019 was decreased by kEUR 178 whereas net changes in fair value of debt investments at FVOCI was reduced by kEUR 48. For the nine month ended September 2019 the loss was reduced by kEUR 346 whereas net changes in fair value of debt investments at FVOCI was reduced by kEUR 188.

As of December 31, 2019, non current financial assets as well as deferred tax liabilities have increased by kEUR 260 and kEUR 73, respectively. As of December 31, 2019 the balance of accumulated deficit decreased by kEUR 243 whereas the balance of accumulated other comprehensive gain was reduced by kEUR 56.

The Company has evaluated the effect of these amendments, both qualitatively and quantitatively, and concluded that the change did not have a material impact on, nor require amendment of, any previously filed financial statements. Affected financial statement line items for prior periods are appended with a footnote.

2. Summary of significant accounting policies

The principal accounting policies applied in the preparation of these interim financial statements are set out in the Company’s financial statements as of December 31, 2019, which can be found in its Annual Report on Form 20-F that was filed with the U.S. Securities and Exchange Commission. These policies have been applied to all financial periods presented.

Government grants

Government grants in connection with government assistance to help businesses to mitigate adverse impacts from the COVID-19 global pandemic are recognized in profit or loss on a systematic basis over the periods in which the entity recognizes as expenses the related costs for which the grants are intended to compensate, provided that the entity complies with the conditions for the funding.

Short-term investments

In the first quarter of 2020, we amended our classification of short-term investments included in current financial assets. Before the amendment, those short-term investments have been classified in the category at fair value through OCI (FVOCI). For further information, see Note 1.

3. Share based payment arrangements

On April 7, 2017, voxeljet AG established a share option plan that entitles key management personnel and senior employees of voxeljet AG and its subsidiaries to purchase shares of the parent company.

Total options available under the share option plan are 372,000. On April 7, 2017 279,000 options (75%, Tranche 1) were granted. On April 12, 2018 93,000 options (25%, Tranche 2) were granted.

The vesting conditions include a service condition (the options vest after a period of four years of continued service from the respective grant date) and a market condition (the options may only be exercised if the share price exceeds the exercise price over a period of 90 consecutive days by at least 20% in the period between the grant date and the respective exercise time frame) which both conditions must be met.

The fair value of the employee share option plan has been measured for Tranches 1 and 2 using a Monte Carlo simulation. The market condition has been incorporated into the fair value at grant date.

The inputs used in the measurement of the fair value at grant date are as follows:

 

 

 

 

 

 

 

Tranche 1

 

Tranche 2

Parameter

 

 

Share price at grant date

 

USD 13.80

 

USD 16.15

Exercise price

 

USD 13.90

 

USD 16.15

Expected volatility

 

55.00%

 

58.40%

Expected dividends

 

 

Risk-free interest rate

 

2.49%

 

2.85%

Fair value at grant date

 

USD 8.00

 

USD 9.74

The respective expected volatility has been based on an evaluation of the historical volatility of the Company’s share price as at the grant date. As at September 30, 2020 no options are exercisable and 353,400 options are outstanding. The weighted-average contractual life of the options at September 30, 2020 amounts to 6.8 years (September 30, 2019: 7.8 years).

The expenses recognized in the profit and loss statement in relation to the share-based payment arrangements amounted to kEUR 169 in the three months and kEUR 501 in the nine months ended September 30, 2020. (Three months and nine months ended September 30, 2019: kEUR 169 and kEUR 501, respectively).

4. Inventories

 

 

 

 

 

 

 

9/30/2020

 

12/31/2019

 

 

(€ in thousands)

Raw materials and merchandise

 

3,947

 

4,109

Work in progress

 

10,052

 

8,350

Total

 

13,999

 

12,459

5. Property, plant and equipment, net

 

 

 

 

 

 

 

9/30/2020

 

12/31/2019

 

 

(€ in thousands)

Land, buildings and leasehold improvements

 

19,081

 

20,045

Plant and machinery

 

4,516

 

5,779

Other facilities, factory and office equipment

 

1,264

 

1,459

Assets under construction and prepayments made

 

58

 

60

Total

 

24,919

 

27,343

Thereof pledged assets of Property, Plant and Equipment

 

13,362

 

6,618

In March 2020, voxeljet registered a first rank land charge amounting to kEUR 10,000 on its land and facility located in Friedberg, Germany as collateral in favor of the European Investment Bank (“EIB”) related to the loan, entered into with the EIB under the Finance Contract, dated November 9, 2017.

6. Other liabilities and provisions

 

 

 

 

 

 

 

9/30/2020

 

12/31/2019

 

 

(€ in thousands)

Liabilities from payroll

 

279

 

301

Accruals for vacation and overtime

 

228

 

190

Employee bonus

 

211

 

397

Accruals for compensation of Supervisory board

 

135

 

180

Accrual for warranty

 

73

 

241

Accruals for licenses

 

48

 

62

Accruals for education and training

 

47

 

Accruals for commissions

 

37

 

38

Liabilities from VAT

 

30

 

32

Accruals for wage continuation

 

26

 

Accruals for employer’s liability insurance coverage

 

15

 

16

Customers with a credit balance

 

13

 

8

Accrual for restructuring

 

2

 

604

Security deposit

 

 

178

Others

 

56

 

82

Total

 

1,200

 

2,329

7. Financial instruments

The following table shows the carrying amounts and fair values of financial assets and financial liabilities, including their levels in the fair value hierarchy. In addition, for the current year the fair value disclosure of lease liabilities is not required.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Carrying amount

 

Fair Value

 

 

 

 

 

 

Assets at

 

Liabilities

 

Total

 

 

 

 

 

 

 

 

 

 

FVTPL

 

FVOCI

 

amortized

 

at amortized

 

carrying

 

 

 

 

 

 

 

 

9/30/2020

 

 

 

 

 

cost

 

cost

 

amount

 

Level 1

 

Level 2

 

Level 3

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

5,975

 

 

5,975

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial assets

 

2,922

 

 

 

 

2,922

 

2,922

 

 

 

2,922

Bond funds

 

922

 

 

 

 

922

 

922

 

 

 

922

Bond funds (restricted)

 

2,000

 

 

 

 

2,000

 

2,000

 

 

 

2,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade receivables, net

 

 

 

4,630

 

 

4,630

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial assets

 

2,760

 

5

 

 

 

2,765

 

 

2,760

 

5

 

2,765

Derivative financial instruments

 

2,760

 

 

 

 

2,760

 

 

2,760

 

 

2,760

Equity securities

 

 

5

 

 

 

5

 

 

 

5

 

5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade payables

 

 

 

 

2,095

 

2,095

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial liabilities

 

 

 

 

700

 

1,021

 

 

 

1,151

 

1,151

Long-term debt

 

 

 

 

700

 

700

 

 

 

1,151

 

1,151

Lease liability

 

 

 

 

na

 

321

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial liabilities

 

394

 

 

 

22,175

 

25,542

 

 

394

 

24,730

 

25,124

Derivative financial instruments

 

394

 

 

 

 

394

 

 

394

 

 

394

Long-term debt

 

 

 

 

22,175

 

22,175

 

 

 

24,730

 

24,730

Lease liability

 

 

 

 

na

 

2,973

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Carrying amount

 

Fair Value

 

 

 

 

 

 

Assets at

 

Liabilities

 

Total

 

 

 

 

 

 

 

 

 

 

FVTPL

 

FVOCI

 

amortized

 

at amortized

 

carrying

 

 

 

 

 

 

 

 

12/31/2019

 

 

 

 

 

cost

 

cost

 

amount

 

Level 1

 

Level 2

 

Level 3

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

4,368

 

 

4,368

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial assets

 

6,945

 

 

463

 

 

7,408

 

6,945

 

 

 

6,945

Bond funds (1)

 

3,667

 

 

 

 

3,667

 

3,667

 

 

 

3,667

Bond funds (restricted) (1)

 

2,000

 

 

 

 

2,000

 

2,000

 

 

 

2,000

Note receivable (1)

 

1,278

 

 

 

 

1,278

 

1,278

 

 

 

1,278

Restricted Cash

 

 

 

463

 

 

463

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade receivables, net

 

 

 

5,915

 

 

5,915

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial assets

 

2,274

 

 

 

 

2,279

 

 

2,014

 

5

 

2,019

Derivative financial instruments (2)

 

2,274

 

 

 

 

2,274

 

 

2,014

 

 

2,014

Equity securities

 

 

5

 

 

 

5

 

 

 

5

 

5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade payables

 

 

 

 

2,797

 

2,797

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial liabilities

 

 

 

 

10,864

 

11,290

 

 

 

10,858

 

10,858

Long-term debt (2) (3)

 

 

 

 

10,864

 

10,864

 

 

 

10,858

 

10,858

Lease liability

 

 

 

 

na

 

426

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial liabilities

 

 

 

 

6,682

 

9,866

 

 

 

6,148

 

6,148

Long-term debt (2) (3)

 

 

 

 

6,682

 

6,682

 

 

 

6,148

 

6,148

Lease liability

 

 

 

 

na

 

3,184

 

 

 

 

(1)Comparative figures for the year ended December 31, 2019 were revised related to the amendment of classification of short-term investments. For further information, see Note 1 of the interim consolidated financial statements.

(2)Comparative figures for the year ended December 31, 2019 were revised related to the recalculation of the performance participation interest related to the Finance Contract with the EIB. For further information, see Note 1 of the interim consolidated financial statements.

(3)Previously presented under level 2.

The valuation techniques used to value financial instruments include the use of quoted market prices or dealer quotes for similar instruments as well as discounted cash flow analysis.

The fair value of the Company’s investments in the bond funds and note receivable was determined based on the quoted unit prices received by the fund management company.

The fair value of the derivative financial instruments that are not traded in an active market is determined using valuation techniques which maximise the use of observable market data and rely as little as possible on entity-specific estimates. The fair values have been determined based on share prices and the discount rates used were adjusted for counterparty or own credit risk.

The fair value of long-term debt was determined using discounted cash flow models based on the relevant forward interest rate yield curves, considering the credit risk of voxeljet.

Due to their short maturity and the current low level of interest rates, the carrying amounts of cash and cash equivalents, restricted cash, trade receivables, trade payables, credit lines and bank overdrafts approximate fair value.

The group’s policy is to recognize transfers into and transfers out of fair value hierarchy levels as at the end of the reporting period.

In September 2020, there were no transfers of financial instruments measured at fair value between level 1 and level 2.

8. Financial result

 

 

 

 

 

 

 

Three months ended September 30,

 

 

2020

 

2019

 

 

(€ in thousands)

Interest expense

 

(1,005

)

 

(325

)

Interest expense on lease liability

 

(36

)

 

(50

)

Long-term debt

 

(486

)

 

(254

)

Expense from revaluation of derivative financial instruments

 

(481

)

 

 

Other

 

(2

)

 

(21

)

Interest income

 

77

 

 

184

 

Payout of bond funds

 

29

 

 

44

 

Income from revaluation of derivative financial instruments (2)

 

 

 

74

 

Fair value valuation of financial assets (1)

 

47

 

 

63

 

Other

 

1

 

 

3

 

Financial result

 

(928

)

 

(141

)

 

 

 

 

 

 

 

Nine months ended September 30,

 

 

2020

 

2019

 

 

(€ in thousands)

Interest expense

 

(1,692

)

 

(934

)

Interest expense on lease liability

 

(127

)

 

(145

)

Long-term debt (2)

 

(1,094

)

 

(745

)

Expense from revaluation of derivative financial instruments

 

(394

)

 

 

Fair value valuation of financial assets (1)

 

(73

)

 

 

Other

 

(4

)

 

(44

)

Interest income

 

573

 

 

447

 

Payout of bond funds

 

74

 

 

115

 

Income from revaluation of derivative financial instruments (2)

 

486

 

 

133

 

Fair value valuation of financial assets (1)

 

 

 

188

 

Other

 

13

 

 

11

 

Financial result

 

(1,119

)

 

(487

)

(1)Comparative figures for the three and nine months ended September 30, 2019 were revised related to the amendment of classification of short-term investments. For further information, see Note 1 of the interim consolidated financial statements.

(2)Comparative figures for the three and nine months ended September 30, 2019 were revised related to the recalculation of the performance participation interest related to the Finance Contract with the EIB. For further information, see Note 1 of the interim consolidated financial statements.

9. Segment reporting

The following table summarizes segment reporting. The sum of the amounts of the two segments equals the total for the Group in each of the periods.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended September 30,

 

 

2020

 

 

 

 

2019

 

 

 

 

 

(€ in thousands)

 

 

 

 

 

 

CONSO

 

 

 

 

 

 

 

CONSO

 

 

 

 

SYSTEMS

 

SERVICES

 

LIDATION

 

GROUP

 

SYSTEMS

 

SERVICES

 

LIDATION

 

GROUP

Revenues

 

2,836

 

 

2,222

 

 

(150

)

 

4,908

 

 

1,966

 

 

2,800

 

 

(330

)

 

4,436

 

third party

 

2,686

 

 

2,222

 

 

 

 

4,908

 

 

1,636

 

 

2,800

 

 

 

 

4,436

 

intra-segment

 

150

 

 

 

 

(150

)

 

 

 

330

 

 

 

 

(330

)

 

 

Cost of sales

 

(1,626

)

 

(1,675

)

 

 

 

(3,301

)

 

(1,279

)

 

(2,292

)

 

 

 

(3,571

)

Gross profit

 

1,060

 

 

547

 

 

 

 

1,607

 

 

357

 

 

508

 

 

 

 

865

 

Gross profit in %

 

39.5

%

 

24.6

%

 

 

 

32.7

%

 

21.8

%

 

18.1

%

 

 

 

19.5

%

Operating Expenses

 

 

 

 

 

 

 

(4,254

)

 

 

 

 

 

 

 

(5,142

)

Other operating expenses

 

 

 

 

 

 

 

(590

)

 

 

 

 

 

 

 

(36

)

Other operating income

 

 

 

 

 

 

 

223

 

 

 

 

 

 

 

 

787

 

Operating loss

 

 

 

 

 

 

 

(3,014

)

 

 

 

 

 

 

 

(3,526

)

Finance expense (1) (2)

 

 

 

 

 

 

 

(1,005

)

 

 

 

 

 

 

 

(325

)

Finance income (1) (2)

 

 

 

 

 

 

 

77

 

 

 

 

 

 

 

 

184

 

Financial result

 

 

 

 

 

 

 

(928

)

 

 

 

 

 

 

 

(141

)

Loss before income taxes

 

 

 

 

 

 

 

(3,942

)

 

 

 

 

 

 

 

(3,667

)

Income tax income (expense) (2)

 

 

 

 

 

 

 

(93

)

 

 

 

 

 

 

 

(68

)

Net loss

 

 

 

 

 

 

 

(4,035

)

 

 

 

 

 

 

 

(3,735

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine months ended September 30,

 

 

2020

 

 

 

 

2019

 

 

 

 

 

(€ in thousands)

 

 

 

 

 

 

CONSO

 

 

 

 

 

 

 

CONSO

 

 

 

 

SYSTEMS

 

SERVICES

 

LIDATION

 

GROUP

 

SYSTEMS

 

SERVICES

 

LIDATION

 

GROUP

Revenues

 

6,437

 

 

6,846

 

 

(575

)

 

12,708

 

 

6,777

 

 

8,871

 

 

(597

)

 

15,051

 

third party

 

5,862

 

 

6,846

 

 

 

 

12,708

 

 

6,180

 

 

8,871

 

 

 

 

15,051

 

intra-segment

 

575

 

 

 

 

(575

)

 

 

 

597

 

 

 

 

(597

)

 

 

Cost of sales

 

(3,822

)

 

(5,109

)

 

 

 

(8,931

)

 

(4,463

)

 

(6,284

)

 

 

 

(10,747

)

Gross profit

 

2,040

 

 

1,737

 

 

 

 

3,777

 

 

1,717

 

 

2,587

 

 

 

 

4,304

 

Gross profit in %

 

34.8

%

 

25.4

%

 

 

 

29.7

%

 

27.8

%

 

29.2

%

 

 

 

28.6

%

Operating Expenses

 

 

 

 

 

 

 

(13,567

)

 

 

 

 

 

 

 

(15,011

)

Other operating expenses

 

 

 

 

 

 

 

(1,958

)

 

 

 

 

 

 

 

(422

)

Other operating income

 

 

 

 

 

 

 

1,258

 

 

 

 

 

 

 

 

1,468

 

Operating loss

 

 

 

 

 

 

 

(10,490

)

 

 

 

 

 

 

 

(9,661

)

Finance expense (1) (2)

 

 

 

 

 

 

 

(1,692

)

 

 

 

 

 

 

 

(934

)

Finance income (1) (2)

 

 

 

 

 

 

 

573

 

 

 

 

 

 

 

 

447

 

Financial result

 

 

 

 

 

 

 

(1,119

)

 

 

 

 

 

 

 

(487

)

Loss before income taxes

 

 

 

 

 

 

 

(11,609

)

 

 

 

 

 

 

 

(10,148

)

Income tax income (expense) (2)

 

 

 

 

 

 

 

(150

)

 

 

 

 

 

 

 

(123

)

Net loss

 

 

 

 

 

 

 

(11,759

)

 

 

 

 

 

 

 

(10,271

)

(1)Comparative figures for the three and nine months ended September 30, 2019 were revised related to the amendment of classification of short-term investments. For further information, see Note 1 of the interim consolidated financial statements.

(2)Comparative figures for the three and nine months ended September 30, 2019 were revised related to the recalculation of the performance participation interest related to the Finance Contract with the EIB. For further information, see Note 1 of the interim consolidated financial statements.

10. Revenues

 

 

 

 

 

 

 

 

 

 

 

Three months ended September 30,

 

 

2020

 

2019

 

2020

 

2019

 

 

SYSTEMS

 

SERVICES

 

 

(€ in thousands)

Primary geographical markets

 

 

 

 

 

 

 

 

EMEA

 

1,025

 

946

 

1,364

 

1,639

Asia Pacific

 

309

 

221

 

223

 

212

Americas

 

1,352

 

469

 

635

 

949

 

 

2,686

 

1,636

 

2,222

 

2,800

 

 

 

 

 

 

 

 

 

Timing of revenue recognition

 

 

 

 

 

 

 

 

Products transferred at a point in time

 

2,392

 

1,235

 

2,222

 

2,800

Products and services transferred over time

 

294

 

401

 

 

Revenue from contracts with customers

 

2,686

 

1,636

 

2,222

 

2,800

 

 

 

 

 

 

 

 

 

 

 

Nine months ended September 30,

 

 

2020

 

2019

 

2020

 

2019

 

 

SYSTEMS

 

SERVICES

 

 

(€ in thousands)

Primary geographical markets

 

 

 

 

 

 

 

 

EMEA

 

3,290

 

2,782

 

4,190

 

5,119

Asia Pacific

 

704

 

1,151

 

683

 

712

Americas

 

1,868

 

2,247

 

1,973

 

3,040

 

 

5,862

 

6,180

 

6,846

 

8,871

 

 

 

 

 

 

 

 

 

Timing of revenue recognition

 

 

 

 

 

 

 

 

Products transferred at a point in time

 

5,074

 

5,360

 

6,846

 

8,871

Products and services transferred over time

 

788

 

820

 

 

Revenue from contracts with customers

 

5,862

 

6,180

 

6,846

 

8,871

 

 

 

 

 

 

 

 

 

 

 

Three months ended September 30,

 

Nine months ended September 30,

 

 

2020

 

2019

 

2020

 

2019

 

 

(€ in thousands)

EMEA

 

2,389

 

2,585

 

7,480

 

7,901

Germany

 

834

 

1,231

 

3,644

 

3,606

France

 

189

 

399

 

686

 

1,039

Switzerland

 

102

 

54

 

195

 

494

Great Britain

 

205

 

270

 

765

 

980

Others

 

1,059

 

631

 

2,190

 

1,782

Asia Pacific

 

532

 

433

 

1,387

 

1,863

China

 

326

 

242

 

816

 

734

South Korea

 

160

 

134

 

428

 

481

Others

 

46

 

57

 

143

 

648

Americas

 

1,987

 

1,418

 

3,841

 

5,287

United States

 

1,981

 

1,289

 

3,722

 

5,096

Others

 

6

 

129

 

119

 

191

Total

 

4,908

 

4,436

 

12,708

 

15,051

11. Commitments, contingent assets and liabilities

In March 2018, ExOne GmbH, a subsidiary of ExOne, notified voxeljet of its intent not to pay its annual license fees under an existing intellectual property-related agreement and asserted its rights to claim damages pursuant to an alleged material breach of the agreement. At this time, the Company cannot reasonably estimate a contingency, if any, related to this matter.

In connection with the enforcement of voxeljet’s intellectual property rights, the acquisition of third‑party intellectual property rights, or disputes related to the validity or alleged infringement of the Company’s or a third‑party’s intellectual property rights, including patent rights, voxeljet has been and may in the future be subject or party to claims, negotiations or complex, protracted litigation.

12. Related party transactions

 

 

 

 

 

Name

 

Nature of relationship

 

Duration of relationship

Franz Industriebeteiligungen AG, Augsburg

 

Lessor

 

10/01/2003 – Current

Schlosserei und Metallbau Ederer, Dießen

 

Supplier

 

05/01/1999 – Current

Andreas Schmid Logistik AG, Gersthofen

 

Supplier

 

05/01/2017 – Current

Suzhou Meimai Fast Manufacturing Technology Co., Ltd, Suzhou

 

Minority shareholder of voxeljet China, Customer

 

04/11/2016 – Current

DSCS Digital Supply Chain Solutions GmbH, Gersthofen

 

Customer

 

05/11/2017 – Current

Michele Neuber

 

Employee

 

07/01/2019 – Current

Transactions with Franz Industriebeteiligungen AG comprise the rental of office space in Augsburg, Germany. Rental expenses amounted to kEUR 2, in each, the nine months ended September 30, 2020 as well as the nine months ended September 30, 2019.

Furthermore, voxeljet acquired goods amounting to kEUR 0 and kEUR 0 in the nine months ended September 30, 2020 and 2019, respectively from ‘Schlosserei und Metallbau Ederer’, which is owned by the brother of Dr. Ingo Ederer, the Chief Executive Officer of voxeljet.

In addition, voxeljet received logistics services amounting to kEUR 25 and kEUR 43 in the nine months ended September 30, 2020 and 2019, respectively from ‘Andreas Schmid Logistik’, where the member of our supervisory board Dr. Stefan Söhn serves as the Chief Financial Officer.

Moreover, voxeljet received orders amounting to kEUR 19 and kEUR 136 in the nine months ended September 30, 2020 and 2019, respectively from ‘Suzhou Meimai Fast Manufacturing Technology Co., Ltd., which is our minority shareholder for voxeljet China.

Further, voxeljet received orders amounting to kEUR 0 and kEUR 11 in the in the nine months ended September 30, 2020 and 2019, respectively from ‘DSCS Digital Supply Chain Solutions GmbH’, which is an associated company where we own 33.3%.

In addition, voxeljet employed Michele Neuber as an intern, the son of Volker Neuber, who is member of our supervisory board since July 2020. He received a salary of kEUR 1 and kEUR 1 in the nine months ended September 30, 2020 and 2019, respectively.

All related party transactions, voxeljet entered into, were made on an arm’s length basis.

13. Subsequent events

By resolution of its supervisory board dated November 12, 2020, the current members of the Company’s management board, Dr. Ingo Ederer and Rudolf Franz, were reappointed as members of the management board for a new three year term from July 1, 2021 until June 30, 2024. Dr. Ingo Ederer and Rudolf Franz have each accepted such new appointment.

Following the reappointment of Dr. Ingo Ederer and Rudolf Franz as members of the management board, each of Dr. Ingo Ederer and Rudolf Franz entered into a new three year service agreement effective as of July 1, 2021. The current service agreements will expire at the end of their current term of office on June 30, 2021.

The main terms of the service agreements are summarized below. The terms of the service agreements of Dr. Ingo Ederer and Rudolf Franz are identical with only a few deviating provisions regarding the company car and social security payments.

Each service agreement can be terminated prior to June 30, 2024 only, (i) by the member of the management board exercising a special termination right (Sonderkündigungsrecht) in case of a change of control of voxeljet (as defined in the service agreement), if and to the extend such change of control leads to a material change of the position of the member of the management board, if (ii) the member of the management board is terminated by the Company for cause or if (iii) the member of the management board terminates the service agreement for cause.

If a member of the management board terminates the service agreement exercising the special termination right (Sonderkündigungsrecht) in case of a change of control, the member of the management board is entitled to a compensation payment. Such compensation payment consists of the sum of 50% of the total remuneration payable to the member of the management board over the outstanding full term of the service agreement (fixed plus variable remuneration assuming the full achievement of all bonus targets) and a lump sum payment amounting to two annual fixed salaries. The compensation payment is capped at the amount of EUR 1,425,000.

Under German law, a contract can be terminated for cause only in exceptional circumstances (i.e., if the continuation of the contractual relationship is unacceptable for the terminating party). Termination for cause generally requires that a party repeatedly and severely breaches its contractual duties. To the extent the employment terminates during a business year, the member of the management board is entitled to a pro rata portion of the bonus that reflects the percentage of the year that the member of the management board worked for the Company.

Furthermore, each service agreement contains a covenant pursuant to which each member of the management board has agreed not to compete with the Company for a period of two years after the termination of the service agreement. Under German law, a non-compete covenant is only valid if the employee is compensated during the term of the non-compete obligation. As compensation for the non-compete covenant, each member of the management board will receive 100% of his fixed salary (but in no event less than 50% of the total compensation received in the preceding year) for the entire two year term of the non-compete covenant. If the service agreement of a member of the management board is terminated for cause, the Company is not obligated to pay the compensation for the non-compete covenant, so long as the Company provides the member of the management board with a written statement disclaiming the Company’s obligation to pay this compensation within one month after the termination.

The new service agreements provide for an annual fixed compensation (base salary), an annual performance award (annual bonus) with a target of up to 30% of the yearly base salary, as well as a long-term performance award for a three-business-year period (long-term bonus) with a target of up to 100% of the yearly base salary. The performance targets of the annual and long-term bonuses are a mixture of certain financial and non-financial targets, such as revenue, profitability and liquidity targets as well as personal goals. In addition to the fixed and variable remuneration components, each member of the management board is entitled to additional benefits (including company car arrangements, mobile phone, accident and director and officer liability insurance) and reimbursement of necessary and reasonable expenses. In addition, the supervisory board can grant stock options to the members of the management board on the basis of a stock option plan.

Based on the aforementioned fixed and variable bonus payments and the perquisites related to company car, each of Dr. Ederer and Mr. Franz would be entitled to a maximum compensation of up to EUR 491,400 per year of the agreement.

The foregoing description of the service agreements is qualified in its entirety by reference to the full text of each of Dr. Ingo Ederer’s and Rudolf Franz’s service agreement, copies of which are attached hereto as Exhibit 10.1 and 10.2, respectively, and incorporated herein by reference.

Investors and Media

Johannes Pesch

Director Investor Relations and Business Development

[email protected]

Office: +49 821 7483172

Mobile: +49 176 45398316

KEYWORDS: New York Germany Europe United States North America

INDUSTRY KEYWORDS: Engineering Chemicals/Plastics Technology Manufacturing Other Technology Other Manufacturing Hardware

MEDIA:

Logo
Logo

Scott’s Liquid Gold-Inc. Reports Third Quarter Results

Scott’s Liquid Gold-Inc. Reports Third Quarter Results

Third Quarter 2020 Highlights:

  • Net sales of $7.2 million, negatively impacted by COVID-related supply chain issues, partially offset by Biz and Dryel acquisition
  • Net loss of $0.5 million (($0.04) per share)
    • Includes $0.3 million of expenses related to supply chain transition and Biz and Dryel acquisition
  • Gross margin of 44.8%, an increase of 3.8% from Q3 2019

DENVER–(BUSINESS WIRE)–
Scott’s Liquid Gold-Inc. (OTC: SLGD) today announced operating results for the three months ended September 30, 2020.

President and Chief Executive Officer Mark Goldstein stated, “As we previously announced, pandemic driven raw material and container shortages impacted our third quarter revenue. We have seen limited improvements throughout our supply chain and expect better results in the fourth quarter, though challenges remain.”

Net Sales

Net sales remained level for three months ended September 30, 2020 compared to last year because a decrease in sales due to COVID-driven supply chain shortages was offset by an increase in net sales due to our Kids N Pets, Biz and Dryel acquisitions.

Net sales for the nine months ended September 30, 2020 increased $0.8 million compared to last year due to our Kids N Pets, Biz and Dryel acquisitions, partially offset by decreased sales for multiple product lines due to COVID-related shortages.

Net Loss

Our net loss of $0.5 million for the three months ended September 30, 2020 was primarily driven by COVID-related supply chain issues, increased SG&A expenses attributable to supply chain transition, acquisition-related expenses and interest expense associated with our new debt. These were partially offset by an increase in gross profit driven by the introduction of our Kids N Pets and SLG One products during the fourth quarter of 2019, the introduction of our Biz and Dryel products during the third quarter of 2020, and margin increases associated with outsourcing.

We reported a $0.4 million decrease in net loss for the nine months ended 2020 compared to last year due to our Kids N Pets, Biz and Dryel acquisitions, improved margins due to outsourcing our manufacturing, and a $0.4 million transition payment received related to the termination of our MJ distribution agreement. These decreases in net loss were partially offset by decreased sales caused by COVID-related reduced store traffic and raw material supply chain issues, increased SG&A due to supply chain transition and acquisition-related expenses, gain on sale of equipment during 2019, and interest expense associated with our new debt.

Cash Flow

Cash flow provided by operating activities was $4.3 million for the nine months ended September 30, 2020, as compared to cash flow provided from operating activities of $1.1 million for the same 2019 period. The $3.2 million increase in operating cash flow was primarily the result of our Kids N Pets, Biz, and Dryel acquisitions, as well as our improved margins driven by cost savings from outsourcing.

About Scott’s Liquid Gold-Inc.

Scott’s Liquid Gold-Inc. develops, markets, and sells high-quality, high-value household and personal care products nationally and internationally to mass merchandisers, drugstores, supermarkets, hardware stores, e-commerce retailers, other retail outlets, and to wholesale distributors. Over the last 65+ years we have developed a reputation for delivering products that consumers know and trust.

Our flagship product, Scott’s Liquid Gold® Wood Care, is a leader in its category and is known for bringing life back to and protecting all types of natural wood surfaces. Our Kids N Pets® brands are award winning, safe, nontoxic, stain and odor removing products targeted toward households with children and pets. Our newly acquired Biz and Dryel are top performing laundry care products, with Biz being a top stain removing laundry additive, and Dryel being the market leader in at-home dry cleaning.

Scott’s Liquid Gold-Inc. also owns Neoteric Cosmetics, a personal care company with a rich history of offering products that deliver high-quality, proven results that customers expect. Neoteric’s personal care products are embraced and respected by both medical professionals and consumers alike and include brands such as Alpha® Skin Care, Prell®, and Denorex®. Neoteric Cosmetics is also the proud American specialty channel distributor for Batiste Dry Shampoo.

SCOTT’S LIQUID GOLD-INC. & SUBSIDIARIES

Condensed Consolidated Statements of Operations (Unaudited)

(in thousands, except per share data)

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Net sales

$

7,197

 

 

$

7,178

 

 

$

21,134

 

 

$

20,365

 

Cost of sales

 

3,973

 

 

 

4,235

 

 

 

11,578

 

 

 

12,877

 

Gross Profit

 

3,224

 

 

 

2,943

 

 

 

9,556

 

 

 

7,488

 

Gross Margin

 

44.8

%

 

 

41.0

%

 

 

45.2

%

 

 

36.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Advertising

 

169

 

 

 

105

 

 

 

531

 

 

 

491

 

Selling

 

2,168

 

 

 

1,369

 

 

 

5,371

 

 

 

4,381

 

General and administrative

 

1,377

 

 

 

1,223

 

 

 

4,284

 

 

 

3,604

 

Total operating expenses

 

3,714

 

 

 

2,697

 

 

 

10,186

 

 

 

8,476

 

(Loss) income from operations

 

(490

)

 

 

246

 

 

 

(630

)

 

 

(988

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

 

 

28

 

 

 

3

 

 

 

89

 

Interest expense

 

(137

)

 

 

(5

)

 

 

(215

)

 

 

(14

)

Gain on sale of equipment

 

 

 

 

 

 

 

 

 

 

 

110

 

Other income

 

 

 

 

 

 

 

350

 

 

 

 

(Loss) income before income taxes

 

(627

)

 

 

269

 

 

 

(492

)

 

 

(803

)

Income tax benefit

 

110

 

 

 

118

 

 

 

174

 

 

 

144

 

Net (loss) income

$

(517

)

 

$

387

 

 

$

(318

)

 

$

(659

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income per common share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

$

(0.04

)

 

$

0.03

 

 

$

(0.03

)

 

$

(0.05

)

Diluted

$

(0.04

)

 

$

0.03

 

 

$

(0.03

)

 

$

(0.05

)

Weighted average shares outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

12,480

 

 

 

12,462

 

 

 

12,468

 

 

 

12,435

 

Diluted

 

12,480

 

 

 

12,462

 

 

 

12,468

 

 

 

12,435

 

SCOTT’S LIQUID GOLD-INC. & SUBSIDIARIES

Condensed Consolidated Balance Sheets (Unaudited)

(in thousands, except par value amounts)

 

September 30,

 

 

December 31,

 

 

2020

 

 

2019

 

 

(Unaudited)

 

 

 

 

 

Assets

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

$

174

 

 

$

1,094

 

Accounts receivable, net

 

4,451

 

 

 

2,695

 

Inventories, net

 

5,747

 

 

 

7,841

 

Income taxes receivable

 

107

 

 

 

705

 

Property and equipment held for sale

 

 

 

 

500

 

Prepaid expenses

 

701

 

 

 

368

 

Other current assets

 

 

 

 

71

 

Total current assets

 

11,180

 

 

 

13,274

 

 

 

 

 

 

 

 

 

Property and equipment, net

 

129

 

 

 

124

 

Deferred tax asset

 

692

 

 

 

556

 

Goodwill

 

5,280

 

 

 

3,230

 

Intangible assets, net

 

15,105

 

 

 

8,719

 

Operating lease right-of-use assets

 

3,048

 

 

 

188

 

Other assets

 

38

 

 

 

 

Total assets

$

35,472

 

 

$

26,091

 

 

 

 

 

 

 

 

 

Liabilities and Shareholders’ Equity

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Accounts payable

$

2,959

 

 

$

1,809

 

Accrued expenses

 

589

 

 

 

422

 

Current portion of long-term debt

 

1,000

 

 

 

 

Operating lease liabilities, current portion

 

301

 

 

 

197

 

Total current liabilities

 

4,849

 

 

 

2,428

 

 

 

 

 

 

 

 

 

Long-term debt, net of current portion and debt issuance costs

 

4,031

 

 

 

 

Operating lease liabilities, net of current

 

2,977

 

 

 

19

 

Other liabilities

 

143

 

 

 

27

 

Total liabilities

 

12,000

 

 

 

2,474

 

 

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

 

 

Preferred stock, no par value, authorized 20,000 shares; no shares issued and outstanding

 

 

 

 

 

Common stock; $0.10 par value, authorized 50,000 shares; issued and outstanding 12,513 shares (2020) and 12,462 shares (2019)

 

1,251

 

 

 

1,246

 

Capital in excess of par

 

7,418

 

 

 

7,250

 

Retained earnings

 

14,803

 

 

 

15,121

 

Total shareholders’ equity

 

23,472

 

 

 

23,617

 

Total liabilities and shareholders’ equity

$

35,472

 

 

$

26,091

 

SCOTT’S LIQUID GOLD-INC. & SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows (Unaudited)

(in thousands)

 

Nine Months Ended

 

 

September 30,

 

 

2020

 

 

2019

 

Cash flows from operating activities:

 

 

 

 

 

 

 

Net loss

$

(318

)

 

$

(659

)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

976

 

 

 

552

 

Stock-based compensation

 

106

 

 

 

119

 

Deferred income taxes

 

(136

)

 

 

(150

)

Gain on sale of equipment

 

 

 

 

(110

)

Change in operating assets and liabilities, net of effects of acquisition:

 

 

 

 

 

 

 

Accounts receivable

 

(1,756

)

 

 

336

 

Inventories

 

3,373

 

 

 

787

 

Prepaid expenses and other assets

 

(200

)

 

 

196

 

Income taxes receivable

 

598

 

 

 

1

 

Accounts payable, accrued expenses, and other liabilities

 

1,659

 

 

 

40

 

Total adjustments to net loss

 

4,620

 

 

 

1,771

 

Net cash provided by operating activities

 

4,302

 

 

 

1,112

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

Acquisition

 

(10,529

)

 

 

 

Proceeds from sale of property and equipment

 

500

 

 

 

110

 

Purchase of internal-use software

 

 

 

 

(286

)

Purchase of property and equipment

 

(17

)

 

 

(101

)

Cash paid for leasehold improvements

 

(484

)

 

 

 

Reimbursement for leasehold improvements

 

247

 

 

 

 

Net cash used in investing activities

 

(10,283

)

 

 

(277

)

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

Proceeds from revolving credit facility

 

6,525

 

 

 

 

Repayments of revolving credit facility

 

(3,795

)

 

 

 

Proceeds from term loan

 

3,000

 

 

 

 

Repayments of term loan

 

(167

)

 

 

 

Proceeds from PPP loan

 

600

 

 

 

 

Repayment of PPP loan

 

(600

)

 

 

 

Payments for debt issuance costs

 

(569

)

 

 

 

Proceeds from exercise of stock options

 

67

 

 

 

43

 

Net cash provided by financing activities

 

5,061

 

 

 

43

 

 

 

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalents

 

(920

)

 

 

878

 

 

 

 

 

 

 

 

 

Cash and cash equivalents, beginning of period

 

1,094

 

 

 

6,232

 

Cash and cash equivalents, end of period

$

174

 

 

$

7,110

 

 

 

 

 

 

 

 

 

Supplemental disclosures:

 

 

 

 

 

 

 

Cash paid during the period for interest

$

23

 

 

$

14

 

Note Regarding Forward-Looking Statements

This news release may contain “forward-looking statements” within the meaning of the federal securities laws that are intended to qualify for the Safe Harbor from liability established by the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” generally can be identified by the use of forward-looking terminology such as “assumptions,” “target,” “guidance,” “strategy,” “outlook,” “plans,” “projection,” “may,” “will,” “would,” “expect,” “intend,” “estimate,” “anticipate,” “believe”, “potential,” or “continue” (or the negative or other derivatives of each of these terms) or similar terminology.

Forward-looking statements convey our expectations, intentions, or forecasts about future events, circumstances, or results. All forward-looking statements, by their nature, are subject to assumptions, risks, and uncertainties, which may change over time and many of which are beyond our control. You should not rely on any forward-looking statement as a prediction or guarantee about the future. Actual future objectives, strategies, plans, prospects, performance, conditions, or results may differ materially from those set forth in any forward-looking statement. Some of the factors that may cause actual results or other future events or circumstances to differ from those in forward-looking statements are described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 and the Company’s subsequent Quarterly Reports on Form 10-Q and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statement made by us or on our behalf speaks only as of the date that it was made. We do not undertake to update any forward-looking statement to reflect the impact of events, circumstances, or results that arise after the date that the statement was made, except as required by applicable securities laws. You, however, should consult further disclosures (including disclosures of a forward-looking nature) that we may make in any subsequent filings with the Securities and Exchange Commission.

Investor Relations Contact:

Kevin Paprzycki, CFO

303.576.6032

KEYWORDS: United States North America Colorado

INDUSTRY KEYWORDS: Home Goods Retail Specialty

MEDIA:

Logo
Logo